INCIDENCE OF PREECLAMPSIA IN 200 ANTENATAL ANAEMIC …

118
1 INCIDENCE OF PREECLAMPSIA IN 200 ANTENATAL ANAEMIC MOTHERS ATTENDING A TERTIARY CARE REFFERAL CENTRE AT THE TIME OF ADMISSION AND MATERNAL MORTALITY IN ANAEMIA ASSOCIATED PRE ECLAMPSIA Dissertation submitted to THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY In partial fulfillment of the regulations For the award of the degree of M.D. BRANCH-II OBSTETRICS AND GYNAECOLOGY MADRAS MEDICAL COLLEGE CHENNAI APRIL 2014 CERTIFICATE

Transcript of INCIDENCE OF PREECLAMPSIA IN 200 ANTENATAL ANAEMIC …

1

INCIDENCE OF PREECLAMPSIA IN 200 ANTENATAL ANAEMIC MOTHERS

ATTENDING A TERTIARY CARE REFFERAL CENTRE AT THE TI ME OF

ADMISSION AND MATERNAL MORTALITY IN ANAEMIA ASSOCI ATED

PRE ECLAMPSIA

Dissertation submitted to

THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY

In partial fulfillment of the regulations

For the award of the degree of

M.D. BRANCH-II

OBSTETRICS AND GYNAECOLOGY

MADRAS MEDICAL COLLEGE

CHENNAI

APRIL 2014

CERTIFICATE

2

This is to certify that the dissertation entitled INCIDENCE OF PREECLAMPSIA IN

200 ANTENATAL ANAEMIC MOTHERS ATTENDING A TERTIARY CARE

REFFERAL CENTRE AT THE TIME OF ADMISSION AND MATERNAL

MORTALITY IN ANAEMIA ASSOCIATED PRE ECLAMPSIA is a bonafide work

done by DR. V. POORANA DEVI in the Institute of Social Obstetrics, Govt. Kasturba

Gandhi hospital ( Madras Medical College ) Triplicane, Chennai in partial fulfillment

of the university rules and regulations for award of MS degree in Obstetrics and

Gynecology under my guidance and supervision during the academic year 2011 to 2014.

Prof.DR.V.KANAGASABAI M.D. Prof.DR.S.DILSHATH MD.DGO,

DEAN, Director

Madras Medical College, Institute of Social Obstetrics,

Rajiv Gandhi Govt. General Hospital Govt. Kasturba Gandhi Hospital

Chennai -3 for women and children,

Madras medical college,

Chennai-3

Prof.DR.RAMANI RAJENDRAN MD.DGO.,

GUIDE Institute of Social Obstetrics,

Govt. Kasturba Gandhi Hospital

Madras medical college Chennai

-

3

DECLARATION

I solemnly declare that this dissertation entitled “ INCIDENCE OF

PREECLAMPSIA IN 200 ANTENATAL ANAEMIC MOTHERS ATTENDING A

TERTIARY CARE REFFERAL CENTRE AT THE TIME OF ADMISSION AND

MATERNAL MORTALITY IN ANAEMIA ASSOCIATED PRE ECLAMPSIA was

done by me at The Institute Of Social Obstetrics, Govt. Kasturba Gandhi Hospital,

Madras Medical College during 2011-2014 under the guidance and supervision of

Prof.Dr. RAMANI RAJENDRAN MD,DGO. This dissertation is submitted to the

Tamil Nadu Dr. M.G.R. Medical University towards the partial fulfillment of

requirements for the award of M.D. Degree in Obstetrics and Gynaecology (Branch-II).

Place: Chennai-3 Signature of Candidate

Date: Dr.V.POORANA DEVI M.B.B.S,

MS Post Graduate

Institute of SocialObstetrics,

Government Kastuurba Gandhi Hospital

Chennai.

4

CERTIFICATE BY THE GUIDE

This is to certify that the dissertation entitled “INCIDENCE OF PREECLAMPSIA IN

200 ANTENATAL ANAEMIC MOTHERS ATTENDING A TERTIARY CARE

REFFERAL CENTRE AT THE TIME OF ADMISSION AND MATERNAL

MORTALITY IN ANAEMIA ASSOCIATED PRE ECLAMPSIA is a bonafide

research work done by Dr. V.Poorana devi in partial fulfillment of the requirement for

the degree of Master of Surgery in Obstetrics and Gynaecology.

Prof.DR.RAMANIRAJENDRANMD.DGO

GUIDE Institute of Social Obstetrics,

Government Kasturba Gandhi hospital

Madras medical college

Chennai

Place;

Date;

5

ACKNOWLEDGEMENT

I sincerely thank Prof. Dr. V.KANAGA SABAI MD., Dean,Madras medical college, Chennai, for

granting me permission to use the facilities of the Institution and Hospital for this study.

I expess my gratitude and thanks to Prof.Dr.S. DILSATHM.D.,DGO., Director , Institute of social

obstetrics Government Kasturba Gandhi Hospital for women and children for her guidance.

I am greatly indepted to Prof.Dr.RAMANI RAJENDRAN, M.D.,DGO.,Deputy Superindendent ,

Government Kasturba Gandhi Hospital for women and children, for her meticulous

commitment, constant support, and encouragement throughout this dissertation.

Iam extremely grateful to Dr. Sampath kumarai M.D.,D.G.O., Registrar, Govt. Kasturba Gandhi

Hospital for women and children for giving me inspirations, wise directions at every stage in

bringing out this dissertation.

I also thank Mr. Ravanan , who helped me in completing the statistical work.

I also thank all the unit Chiefs, Assistants, Lab Technicians and all my colleagues for their

continuous support.

I also thank all the patients for their kind cooperation.

6

ABSTRACT

OBJECTIVES AND BACKGROUND

Anemia during pregnancy is a major public health problem especially in

developing countries like India. This prospective study is aimed to find out the

incidence of preeclampsia in mild, moderate, and severe anemia and to analyse the

synergistic effect of anemia with preeclampsia in pregnancy associated Morbidity and

Mortality .

METHODS;

This prospective observational study was carried out at

Govt.KasturbaGandhi Hospital for women and children,Madras medical college,

Chennai,during the period of December 2012 to December 2013 on 200 patients

.Pregnant women attending the antenatal out patient department and labour ward in

Govt.Kasturba Gandhi Hospital with hemoglobin value less than 11gms and after 20

weeks of gestation were selected for the study. After recording the base line data,

patients with moderate and severe anemia were advised admission for anemia evaluation

and treatment .In these patients the incidence of preeclampsia at the time of admission

were calculated. The patients with preeclampsia were admitted for preeclampsia

evaluation The selected patients were monitored and followed till delivery

RESULTS;

In this study 83% of the patients were in the moderate anemia with Hb 7.to 10

gms. 11% of the patients were in the severe anemia with Hb less than7grams and 6% of

the cases were in the mild anemia (Hb 10-11gms). This study was showed the

7

association between anemia and the preeclampsia, anemic patients were more prone to

develop preeclampsia due to associated hypo proteinemia. More severe the anemia,

greater the chance to get preeclampsia. Incidence of preeclampsia in the study was

18.5%, the p value shows .000 highly significant Incidence of severe preeclampsia was

11.5% and incidence of mild preeclampsia was 7%.Maternal outcome of the study

showed that AtonicPPH -6%.Pulmonary edema -1.5%, Death occurred in one case in

the studypopulation.Both HELLP and DIVC occurred in one case 0.5%.Abruptio

placenta occurred in 1%.Eclampsia occurred in 2% of the cases.

CONCLUSION

Anemia during pregnancy is still continues to be a major problem in developing

countries with maternal and fetal complications The coexistence of preeclampsia in

anemic women’s worsening the situation. In preeclampsia, there was already

intravascular volume depletion hence anemia gets masked the patients are not able to

cope up even with mild blood loss during delivery .Correct diagnosis and treatment of

the underlying cause can improve the maternal outcome

.We have to counsel the pregnant mothers during their antenatal checkup regarding the

importance of blood pressure monitoring, screening and correction of anemia prior to

pregnancy and Iron and folic acid supplementation. The Tenth plan strategies has to be

effectively implemented to all pregnant women with anemia to reduce the maternal

mortality and morbidity and long term consequences of anemia.

8

ABBREVIATIONS

ANC- Ante natal care

APH Antepartum haemorrhage

BMI Body mass index

CDC Centre for Disease Control

FEP Free Erythrocyte protoporphyrin

FGR Fetal growth restriction

Hb Hemoglobin

Ig Immunoglobin

iv Intra venous

MCH Mean corpuscular hemoglobin

MCHC Mean corpuscular hemoglobin concentration

MCV Mean corpuscular volume

PCV Packed cell volume

PHC Primary Health Centre

PIH Pregnancy induced hypertension

PPH Post partum hemorrhage

Mgso4 Magnesium sulphate

RBC Red blood cell

TfR Transferrin receptor

TIBC Total iron binding capacity

UTI Urinary tract infection

WHO World Health Organization

9

CONTENTS

SERIAL NUMBER

TITLE PAGE NUMBER

1 INTRODUCTION 1

2 REVIEW OF LITERATURE 3

3 H ISTORICAL ASPECTS OF ANEMIA 8

4 HISTORICAL ASPECTS OF PRE ECLAMPSIA 9

5 ANEMIA IN PREGNANCY 11

5.1 DEFINITION 11

5.2 SEVERITY OF ANEMIA 11

5.3 HAEMATOLOGICAL CHANGES DURING PREGNANCY 12

5.4 CHANGES IN BLOOD CONSTITUENTS 13

5.5 CHANGES IN BLOOD COAGULATION 14

5.6 CLASSIFICATION OF ANEMIA 15

5.7 ERYTROPOIESIS 18

5.8 IRON METABOLISM 18

5.9 IRON DISTRIBUTIONIN THE BODY 19

5.10 IRON DEFICIENCY ANEMIA 20

5.10.1 AETIOLOGY 20

5.10.2 FACTORS AFFECTING IRON ABSORPTION 21

5.10.3 IRON REQUIREMENT DURING PREGNANCY 22

5.10.4 CLINICAL FEATURES 23

5.10.5 HAEMATOLOGICAL INDICES 24

5.10.6 SPECIFIC INVESTIGATIONS FOR IRON DEFICIENCY 26

5.11 EFFECT OF ANEMIA ON PREGNANCY 28

10

5.12 CARE OF ANTENATAL WOMEN WITH ANEMIA 29

5.13 PHARMACOLOGICAL THERAPY OF ANEMIA 30

5.14 BLOOD TRANSFUSION 31

5.15 INTRAPARTUM MANAGEMENT 32

5.16 POSTPARTUM MANAGEMENT 32

6 PRE ECLAMPSIA 33

6.1 DEFINITION 33

6.2 CLASSIFICATION OF HYPERTENSIVE DISORDERS OF PREGNANCY

33

6.3 ETIOLOGY 35

6.4 RISK FACTORS FOR PREECLAMPSIA 36

11

SERIAL NUMBER

TITLE PAGE NUMBER

6.5 PATHOGENESIS 38

6.6 PATHOLOGICAL CHANGES IN ORGANS 39

6.7 CLINICAL FEATURES 41

6.8 INVESTIGATIONS 42

6.9 MANAGEMENT 43

6.10 MILD PREECLAMPSIA 47

6.11 SEVERE PREECLAMPSIA 47

6.11.1 MATERNAL MONITORING 47

6.11.2 FETAL MONITORING 48

6.11.3 INDICATIONS FOR DELIVERY 48

6.11.4 COMPLICATIONS OF SEVERE PREECLAMPSIA 50

7 AIM OF THE STUDY 51

8 MATERIALS AND METHODS 51

8.1 INCLUSION CRITERIA 51

8.2 EXCLUSION CRITERIA 51

8.3 METHODS 52

8.4 STATISTICAL METHODS 43

9 RESULTS AND ANALYSIS 55

10 DISCUSSION 80

10.1 NEAR MISS CASES IN THE STUDY 89

11 SUMMARY 91

12 CONCLUSION 93

13 BIBILIOGRAPHY

14 PROFORMA

15 MASTER CHART

12

LIST OF TABLES

S.NO TITLE PAGE

NO

1 AGEDISTRIBUTION 56

2 DISTRIBUTION OF GRAVIDITY 57

3 DISTRIBUTION OF SOCIO ECONOMIC CLASS 58

4 DISTRIBUTION OF BOOKING STATUS 59

5 REFERRAL STATUS 60

6 LITERACY STATUS 61

7 DISTRIBUTION OF MATERNAL WEIGHT 62

8 DISTRIBUTION OF GESTATIONAL AGE TABLE 63

9 DISTRIBUTION OF SEVERITY OF ANEMIA 64

10 DISTRIBUTION OF PERIPHERAL SMEAR 65

11

DISTRIBUTION OF PLATELET COUNT 66

12 DISTRIBUTION OF SEVERITY OF BLOOD PRESSURE

67

13 DISTRIBUTION OF URINE ALBUMIN 68

14 DISTRIBUTION OF 24 HOURS URINARY PROTIEN 70

15 ONSET OF LABOUR 71

16 MODE OF DELIVERY 72

17 MATERNAL OUTCOME 73

13

18 FETAL OUTCOME 74

19 BIRTH WEIGHT 75

20 BLOOD TRANSUSION 76

21 CROSS TABLE HEMOGLOBIN AND BLOOPRESSURE

77

22 CROSS TABLE MATERNAL OUTCOME AND BP 79

14

LIST OF FIGURES

S.NO TITLE PAGE NO

1 PIE DIAGRAM SHOWING AGE DISTRIBUTION 56

2 PIE DIAGRAM SHOWING DISTRIBUTION

OFGRAVIDITY

57

3 PIE DIAGRAM SHOWING DISTRIBUTION OF

SOCIOECONOMIC CLASS

58

4 PIE DIAGRAM SHOWING BOOKED STATUS 59

5 PIE DIAGRAM SHOWING REFERRAL STATUS 60

6 PIE DIAGRAM SHOWING LITERACY STATUS 61

7 PIE DIAGRAM SHOWING DISTRIBUTION OF MATERNAL WEIGHT

62

8 PIE DIAGRAM SHOWING DISTRIBUTION OF GESTATIONAL AGE

63

9 PIE DIAGRAM SHOWING SEVERITY OF ANEMIA 64

10 PIE DIAGRAM SHOWING DISTRIBUTION OF PERIPHERAL SMEAR

65

11 PIE DIAGRAM SHOWING DISTRIBUTION OF PLATELET COUNT

66

12 PIE DIAGRAM SHOWING SEVERITY OF BLOOD PRESSURE

67

13 PIE DIAGRAM SHOWING DISTRIBUTION OF URINE ALBUMIN

69

14 PIE DIAGRAM SHOWING ONSET OF LABOUR 71

15

15 PIE DIAGRAM SHOWING MODE OF DELIVERY 72

16 PIE DIAGRAM SHOWING MATERNAL OUTCOME 73

17 PIE DIAGRAM SHOWING FETAL OUTCOME 74

18 PIE DIAGRAM SHOWING BIRTH WEIGHT 75

19 PIE DIAGRAM SHOWING BLOOD TRANSUSION 76

20 CHART SHOWING HEMOGLOBIN AND BLOOD PRESSURE

78

16

I .INTRODUCTION

Anaemia in pregnancy is one of the most important public health

problems. Anemia is the most common medical disorder in pregnancy especially in

developing countries. It is responsible for 20% of direct cause of Maternal Mortality in

developing countries. In recent years, worldwide an estimated five lakh women die as a

result of pregnancy each year. Approximately one quarter of all pregnancy and delivery

related maternal deaths Worldwide occur in India.

The current estimated Maternal Mortality Ratio in India is 301 per 100,000

live births. This translates in to about 80,000 pregnant women dying annually. Most

maternal deaths are preventable% In Asia .more than 70% of maternal deaths are due to

direct complications .Hemorrhage 31%. Sepsis/infection 12% unsafe abortion 6%

.Eclampsia 9% obstructed labour 9%. Severe anemia is a critical underlying factor and

important indirect cause of maternal deaths in India. Most maternal deaths occur

between the third trimester and the first week after delivery

Prevalence of anemia in India is about 60% which is increased to 80%

during pregnancy. Most of the pregnant mothers attending a Antenatal outpatient

department are anemic. During pregnancy the nutritional requirement of iron and folic

acid is increased, pregnancy induced hypervolemia also causes physiological anemia

.The increase in blood volume varies among different women. The increase in blood

volume is mainly affected by an increase in plasma volume 40% much more than the red

cell volume 20%resulting in relative hemodilution of pregnancy. This brings the

haemoglobin decrease to almost by2 gms .This along with the increased demand for iron

leads to physiological anemia of pregnancy.

17

The women in the developing countries enter the pregnancy with depleted

iron stores.because most women are not able to develop adequate iron stores during the

growth period due to poverty ,inadequate intake of nutrients recurrent infections

,menstrual blood loss,and WHO defined anemia of pregnancy as a hemogolobin level of

less than 11g/dl ,or hematocrit less than 33% at any point during pregnancy.

Preeclampsia is a multisystem disorder of unknown etiology and is unique to

pregnant women after 20 weeks of gestation. It is a progressive disease with variable

mode of presentation and rate of progression . Preeclampsia is a clinical diagnosis

consisting of 1)new onset hypertension systolic blood pressure >140,diastolic blood

pressure >90mmHg recorded on two occasions at least 6 hours apart in a previously

normotensive women 2) new onset proteinuria (defined as >300mg/24hour .or >2+ on a

clean catch dipstick in the absence of urinary infection; and new onset significant

nondependent edema. Preeclampsia is classified as either mild or severe ‘’ Preeclampsia

complicates 6-8% of all pregnancies . Preeclampsia and eclampsia contributes to 12% of

all maternal deaths in the developing countries( WHO1999) Perinatal outcomes were

significantly higher in preeclampsia

The present study was undertaken to find out the incidence of Preeclampsia in

mild./ moderate/ severe anemia . and to analyse the synergistic effect of anemia with

preeclampsia in pregnancy associated Morbidity and Mortality

Early detection and treatment of anemia in pregnant women significantly

reduces the Mortality andMorbidity

18

2 .REVIEW OF LITERATURE

Early detection of preeclampsia in anemia complicating pregnancy

significantly reduces the maternal mortality .In preeclampsia patients anemia is usually

masked because of hemoconcentration. If they manifest anemia, it is usually of severe

degree

Abdel Aziem A Ali had done a retrospective case control study at Eastern

Sudan Kassala hospital.. Pregnant women with severe anemia Hb <7gms/dl who

delivered between the period of Jan 2008 to Dec2010 ,medical files of them were

reviewed out of these 41.8% women had anemia and 3.2% had severe anemia .The

corrected risk for preeclampsia was increased only in patients with severe

anemia(OR=3.6,p=0.007) .When compared with women who were not anemic ,the risk

of LBW was 2.5 times more in women with mild/moderate anemia and 8.0 times

increased in women with severe anemia . The risk of preterm delivery proportionately

increased with the severity of anemia. More severe the anemia during pregnancy, the risk

of preeclampsia was increased.1

Fernandez G Diez EM, VelaquezN,Oberto J had done a case control study In

48 middle class pregnant women who were given placebo during gestation were

compared with 88 women who were all given iron and folic acid tablets. 23 women

were found to be having anemia, preeclampsia coexisted in 10 of these women.. The

anemic women associated with preeclampsia had lower transferrin saturation than the

anemic patients. 2

Masoomeh Goodarzi Khoigani had done a prospective cohort study with ,520 Iranian

pregnant women aged 15-45 years, hemoglobin and haematocrit was measured in them

19

during the 6th -11thweeks and 26-30th weeks of pregnancy . The cases who were all

having low levels of hemoglobin during the first half of pregnancy were more chance to

get preeclampsia ,p=0.024, The patients with low levels of hemoglobin during the

second half of pregnancy were associated with increased risk of preterm premature

1rupture of membranes (p=0.01) 3.

Ugur Keshin. Emre Karasahin.Seyit Temel Ceyhan,Ahkara had done a

retrospective study included 162 pregnant women with second trimester Hb levels <

8gms/dl(G1) and they were compared to 160 women with second trimester Hb levels

10gms/dl (G2) at Gulhane Military Medical Academy between Jan 2003 to Dec 2006

Preeclampsia rates of women with Hb <8gs were 8.6% n:14, and women with Hb 10

gms were 3.2%(n:5) respectively p(0.05)4

Vitthal G Kuchake, Sunny G Kolhe, had done a prospective observational study

with 971 pregnant women between July 2009 to Feb 2010 . A total 73 (7.51%)

preeclamptic pregnancy was found in the age group of 18-22 years of age . HELLP

Syndrome was found to be 8% and the women with eclampsia were 10% . 48%

incidence of caesarean mode of delivery was observed in that study..This study stated

that in preeclampsia syndrome ,maternal mortality and morbidity rate was high .5

Patra S et al had done the maternal and perinatal outcomes of 130 severely anemic

pregnant women who had 5 gm/dl or less hemoglobin ,the hemoglobin values were

found at the third trimester and 81% of their population were multiparas ,preterm birth

rate was 69.2%, preeclampsia 17% eclampsia 4% , placental abruption 3% fetal distress

23% low birth weight 24.6% neonatal death 35% (6)

20

Pankaj kumar Prasad pore , Usha patil had studied Maternal anemia and its impact

on the perinatal outcome at Maharastra in a tertiary care Hospital of Pune .The study

group was 126 pregnant women . 46% of the cases were anemic during the time of

delivery.and the ,peripheral smear showed that 78% of cases were normochromic

normocytic , 44% pregnant women were microcytic hypochromic and 2% of the study

group had megaloblastic anemia .Anemia was observed in the women with less than

three antenatal follow up visits , with history of early marriage before 18 years of age

and also women who were not taken Iron and folic acid tablets 7

M A Brown ,C Mackenaie , W Dunmuir, L Roberts, had done a retrospective cohort

study . with 1515 women who were diagnosed as preeclampsia or gestational

hypertension between the period of 1988- 1998 the data was collected from the hospital

records.. 1354 women were followed up,and compared with 333 normal pregnancy

women as per the records were selected randomly as controls during the same period.

All most all cases with normal pregnancy outcome previously were found to be having

normotensive pregnancy . One in 50 women was found hypertensive in their past

pregnancy was developed essential hypertension in next pregnancy . Women with

preeclampsia in their previous pregnancy equally chance to develop either preeclampsia

or gestational hypertension (approximately 14% of each) .while women with gestational

hypertension were more chance to get gestational hypertension (26%) when compared to

preeclampsia(6%) in their next pregnancy. When compared with primiparous women

,multiparous women with gestational hypertension were more chance to develop

preeclampsia (11versus 4%) or gestational hypertension (45 versus 22%) in their

subsequent pregnancies. (8

21

James .N.Martin , Jr ,MD, Brian .K. Rinehart,MD,Warren L .May had conducted a

retrospective analytic study , 777 pregnant patients with class1,2,or3 HELLP syndrome

had compared with 193 women with severe pre eclampsia but with the absence of

HELLP syndrome.About 50% of the cases complicated by class 1 HELLP syndrome

showed significant maternal morbidity. When compared with cases complicated by

severe preeclampsia with the absence of HELLPsyndrome(9)

Attiya Ayaz .TajMuhammad, Shaheryar A Hussain.Sadia Habib,had done a cross

sectional comparative study , to find out the neonatal outcome in babies born of

preeclampsia pregnant women. The study was conducted in Ayub Teaching hospital ,

Abbottabad during the period of Janauary 2007 to June 2007. Study population was 73

cases of preeclampsia ,they had matched with controls for the following variables like

age , gestational age ,and parity.Neonatal outcome report showed that the perinatal

mortality of 328 neonates per 1000 total births. Main cause of death was still births and

intra uterine death..Preeclampsia pregnant patient had more of adverse neonatal

outcome.(10)

Mohammad A Salahat and Abdallah I. Ibrahim was ,conducted a cross sectional study

with 1030 pregnant women in the age group of 16 to 40 years for the assessment of

their hemoglobin .The results of the study showed that anemia was more common

among pregnant women of age group16- 19years, Incidence of anemia was more

common in multiparas than primiparas .Prevalence of anemia was increased during the

third trimester,. The significant increase in alkaline phospatase activity was associated

with increased complications like diabetes mellitus,preeclampsia, proteinuria,and

diabetes with hypertension.(11)

22

JamaiyahHaniff et al had done a multicenter cross sectional observational study at

Malaysia to find out the epidemiological parameters of anemia complicating pregnancies

during the period of February to March 2005.The study population was 1072 pregnant

women. The results showed the prevalence was 35%,most of the study population had

mild anemia.12

J.J.Zhang, J. Grewal,J.P.souza, they used the data from WHO Global Survey for

maternal and perinatal health collected in hospitals from2007-2008 to analyse whether

the several types of anemia were risk factors for developing hypertensive disorders

during pregnancy in the developing countries,the results showed that multiparous women

who had severe anemia were increased chance to get gestational hypertension( ODDS

RATIO 1.58)confidence interval of( 1.15-2.19).

Nulliparous women with severe anemia were having significant correlation with

preeclampsia(OR)3.55; 95% CI2.87-4.41, Multiparous women with severe anemia were

having risk of developing preeclampsia (OR;3.94;95% CI 3.05-5.09).13

23

3.H ISTORICAL ASPECTS OF ANEMIA

Iron deficiency has been described as the most common nutritional deficiency across the

world.William Harvey (1628) was the one who postulated the circulation of blood.

German biochemist Felix Hoppe Seyler (1825-1895) showed that hemoglobin was a

complex of haematin and protein by absorption spectrometry.

Paul ehrlich (1854-1915)was discovered aniline dyes to stain blood films ,which was

used in the study of red blood cell, and the birth of Modern Haematology.-

Wintobe(1985).

In Seventeenth century, Chlorosis was used to denote anemia Most of the features of

chlorosis were similar to that of severe iron deficiency anemia in adolescent girls and

young women.(21)

Gabriel Andril (1797-1876) had noticed and stated that the size of red blood cells in

chlorosis which were very small in size.

In 19 th century the term anemia was coined to denote the clinical condition which was

associated with pallor of the mucous membranes and nails. Davis and Witts (1931)

were found the role of iron therapy in hypochromic anemia in adults. The accurate

measurement of haemoglobin levels was a Twentieth century developmentNow we were

using various modalities to treat anemia like injectable forms of iron therapy, blood

transfusions particularly specific components like packed cells.platelets. fresh frozen

plasma.cryoprecipitate.

24

4.HISTORICAL ASPECTS OF PRE ECLAMPSIA 15

Around 400BC, Hippocrates who stated that the headache accompanied by heaviness

and convulsions during pregnancy was considered bad.In the early years of 18th

century,when only the end stage of toxemia ,eclampsia was known they believed that it

was a special form of epilepsy associated with pregnancy.

In 1739.Bossier de sauvages, differentiated the seizures of eclampsia from epilepsy,

Eclampsia was acute in onset, and it was resolved after removal of the precipitating

factor. Prior to 18th century, the term eclampsia was used to refer the visual phenomena

occurring in neurological diseases, as flashes of light.

Rayer’s (1839-1841) stated that the evidence of renal involvement in eclampsia, he

found that the presence of protein in the urine of pregnant edematous women. Lever

(1843) in London also found that eclampsia was associated with albuminuria. He also

demonstrated that eclampsia was more common in first pregnancies than subsequent

pregnancies, and disappearance of protein in the urine of pregnant women after child

birth.

The term toxemia was used previously to denote eclampsia, when it was believed t o be

caused by toxic substances in the blood, the term is a misnomer.After the invention of

Scipione Riva –Rocci’s mercury manometer (1896) to measure the blood pressure, they

recognized that the preeclampsia was a hyper tensive disorder associated with

pregnancy.

In 1959 Farughar demonstrated renal pathology glomerular endotheliosis in

preeclampsia patients using Electron microscopy

25

In the last two decades ,because of advance reasearches in molecular level,and biological

level the pathophysiological changes associated with preeclampsia like examination of

the placenta, role of spiral arterioles, endothelial cells, antioxidants, antiangiogenic

proteins, and other systemic dysfunction were made out. Still the etiopathogenesis of

preeclampsia is not well understood.

26

5.ANEMIA IN PREGNANCY

5.1.DEFINITION :

Anemia is defined as a hemoglobin value that is lower than the threshold

of two standard deviations below the median value for a healthy matched population.

WHO CRITERIA:

WHO defined anemia of pregnancy as hemoglobin level of less than

11gm/dl, or hematocrit less than 33%, at any point during pregnancy.

CDC CRITERIA

The US Centers for Disease control and Prevention defines anemia of

pregnancy as a hemoglobin level less than 11gms/dl, or hematocrit less than 33% in the

first or third trimester or hemoglobin less than 10.5 g/dl or haematocrit less than 32% in

the second trimester.

5.2 SEVERITY OF ANEMIA

According to ICMR the severity of anemia is graded as follows;

Mild degree :10-10.9gms%

Moderate degree :7- 10gms%

Severe degree:less than 7gms%

Very severe degree: less than 4gms%

Prevalence of anemia is higher in India when compared to other South Asian

Countries. 80% of maternal deaths in South Asia due to anemia occurring in India.

27

5.3HAEMATOLOGICAL CHANGES DURING PREGNANCY

The hematological changes in pregnancy include increases in plasma volume and total

red cell mass and hemoglobin changes thorough out the gestation.

True anemia denotes that the decrease in hemoglobin concentration and fall in the

oxygen carrying capacity of blood. But during pregnancy the oxygen carrying capacity

of the blood is increased than in the non pregnant mothers. This was reflected by

increased oxygen saturation in the venous blood of pregnant women.

The increase in the plasma volume was greater when compared to red cell mass , which

leads to physiological dilution .In the first six weeks of pregnancy ,the plasma volume

decreases ,it begins to raise from sixth week .and reaches plateau after 34-36 weeks. The

maximum rise is about 50% of the base line value.

The blood volume starts to increase from sixth week of gestation, reaches the maximum

of 50-% above the base line value at 30- 32 weeks. In the first 12 weeks of gestation, red

cell mass decreases, then it increases till third trimester which was about 20-30% above

the base line value. Both the plasma volume and redcell mass reaches the prepregnant

value after six weeks of post partum. Because of both physiological anemia during

pregnancy and increased iron demand, anemia is more prevalent among pregnant

women.

The increased maternal circulatory volume.plasma volume, and redcell mass in

association with decreased peripheral resistance leads to increase uteroplacental

circulation , the above mentioned changes are mediated thorough various hormones like

rennin, angiotensin II, aldosterone,thromboxane A2,cortisol,

prostacylin,estrogens,progesterone,anti diuretic hormone, antinatiuretic hormones.

28

The hydremia of pregnancy favours the followings;

1) The hemodilution leads to decrease in blood viscosity which helps in better oxygen

and co2 transport between the maternal and fetal circulation

2) It protects the mother against the blood loss during third stage of labour,

3) The increased blood volume leads to increased glomerular filtration rate; thereby it

regulates the fetal amniotic fluid production,

4) It protects the pregnant women against supine hypotension.

In normal pregnancy

The serum iron concentration decreased.

The absorption of iron from the small intestine increased.

The iron binding capacity also increased.

There is increased synthesis of the beta1 globulin and transferrin.

The plasma folate concentration decreased to 50% at term because of renal clearance of

folate is increased during pregnancy, but red cell folate concentration is minimally

affected.

5.4 CHANGES IN BLOOD CONSTITUENTS

Bone marrow showed erythroid hyper plasia and increased production of reticulocytes

The total white cell count increased particularly poly morpho leucocytes, T and B

lymphocyte count do not change much, but their functional ability is decreased, so that

pregnant women are more prone for getting infections

29

Platelets may show a small reduction in number because of increased thrombaxane levels

in mid trimester, which causes increased platelet consumption. But platelet production is

increased during pregnancy.

Plasma proteins increased during pregnancy, but because of hemodilution, the total

protein value is 6gm/dl (normal 7gm/dl) Albumin also falls to 3gm/dl (normal 4gm/dl)

Globulin is marginally increased. It leads to decrease in colloid osmotic pressure .The

albumin globulin ratio in pregnancy is altered to 1:1, (normal 2:1).

5.5 CHANGES IN BLOOD COAGULATION

In pregnancy, there is increase in all the coagulation factors except factor 10 and factor

12. There is reduction in the concentration of anticoagulation factors like antithrombin

III, protein C, and protein S The activity of the fibrinolytic system is inhibited.Thus

pregnancy is a hyper coagulable state, it helps to prevent hemorrhage during delivery but

it increases the risk of venous thrombosis and pulmonary embolism.

The level of coagulation factors becomes normal in 2weeks after delivery. As a result of

increased fibrinogen level, globulin level and decreased blood viscosity ESR is four fold

increased. Hence ESR value is little significance.

30

5.6 CLASSIFICATION OF ANEMIA

PHYSIOLOGICAL ANEMIA & PATHOLOGICAL ANEMIA

DEFICIENCY ANEMIA

Iron deficiency

Folic acid deficiency

Vitamin B12 deficiency

Protein deficiency

HEMORRHAGIC ANEMIA

Antepartum hemorrhage

Hook worm infestations

Bleeding piles

HEMOLYTIC ANEMIA

Hemoglobinopathies

Thalassemia,Sickle cell anemia,

Hereditary Sperocytosis

Malaria

MISCELLANEOUS CAUSES

Bone marrow insufficiency –Aplastic anemia,Drug induced

Neoplasm

Chronic renal disease Tuberculosis

31

MORPHOLOGICAL CLASSIFICATION

Normocytic MCV: 80-100fl

Microcytic MCV :< 80 fl

Macrocytic MCV :> 100

NORMOCYTIC ANEMIA CAUSES

Aplastic anemia

Acute post hemorrhagic anemia

Hemolytic anemia(except thalassemia)

Pure red cell aplasia

Endocrine diseases

Bone marrow infiltration

Renal failure

Protein malnutrition

MICROCYTIC ANEMIA

Iron deficiency

Sideroblastic anemia

Thalassemia

Lead poisoning

Anemia of chronic diseases

32

MACROCYTIC ANEMIA

Megaloblastic anemia

Non megaloblastic anemia

MEGALOBLASTIC MACROCYTIC ANEMIAS

Folic acid deficiency, Vitamin B12 deficiency

NON MEGALOBLASTIC MACROCYTIC ANEMIAS

Anemia of acute bleeding

Leukemias(acute)

Liver disease

Hemolytic anemias

Myleodysplasic syndrome

Hypothyroidism

Alcoholism

Aplastic anemia

PATHOGENIC CLASSIFICATION

DECREASED HEMOGLOBIN PRODUCTION

Iron deficiency anemia

Sideroblastic anemia

Thalassemia

DEFECTIVE DNA SYNTHESIS

VitaminB12 deficiency , Folic acid deficiency

33

5.7 ERYTROPOIESIS

Red blood cells are formed from Colony forming unit of elytroid

precursors – pronormoblasts- normoblasts- reticulocytes- to mature nucleated

erythrocytes. The red blood cell life span is about 120 days. Under normal conditions,

average weight human destroys 1-2X108 erythrocytes per hour, which was corresponds

to 6 gm hemoglobin turnover. When the hemoglobin is destroyed it produces globin and

heameglobin is again degraded into its constituents amino acids iron content of heme

enters in to the iron pool. The catabolism of heme occurs mainly in the

reticuloendothelial system of the body (liver, spleen .bone marrow).

Adequate nutrients are essential for erythropoiesis, inadequate reserve, or increased

demand, or deficient supply of vitamins and minerals are interfering with normal

erythropoiesis.

5.8 IRON METABOLISM

Iron is present in many of the hemoproteins like hemoglobin, myoglobin,and

cytochromes.It is ingested in the diet either as heme or non heme iron.Absorption of

haem iron is two to three times more than than nonhaemiron.Absorption of iron occurs in

the proximal duodenum by enterocyte .Ferric iron in the food is reduced to ferrous form

by the ferric reductase present on the surface of the enterocyte The transfer of iron from

the apical surface of the enterocyte to the interior is brought by the proton coupled

divalent metal transporter . A newly discovered peptide named as hepcidin plays an

important role in iron metabolism . It down regulates the intestinal absorption and

placental transfer of iron and also release of iron from the macrophages. When the

plasma level of iron is low, the synthesis of hepcidin decreases

34

Once the iron enters in to the enterocyte, it can be stored as ferritin or transferred across

the basement membrane in to the plasma and carried by the transferrin , ferric iron is

taken up by the transferrin One transferrin molecule binds with the two atoms of iron.

The regulation of iron absorption is complex and not well understood. Regulation occurs

at the level of enterocyte ( mucosal block) The concentration of transferrin in the plasma

is 300mg/dl, it binds with the 300mcg of iron per deciliter.it denotes the total iron

binding capacity of the plasma

The amount of ferritin in the plasma can be measured by sensitive and specific radio

immunoassay ,it reflects the body iron stores

Ferritin aggregates to form hemosiderin,ferritin is a water soluble form but hemosiderrin

is water insoluble. When there is a need the stores are first mobilized to provide iron.

5.9 IRON DISTRIBUTIONIN THE BODY

(ref;harper27th edi)

Transferrin 3-4mg

Hemoglobin in red blood cells 2500mg

Myoglobin and other enzymes 300mg

Storage iron 100-400mg

Absoption 1mg/day

Losses 1.5-2mg/day

35

5.10 IRON DEFICIENCY ANEMIA

5.10.1 AETIOLOGY

Deficient intake and absorption

1. Inadequate diet

2. . Presence of phosphates and phytates in the food

3. Hyperemesis

4. Achlorhydria and vitamin C deficiency

INCREASED DEMAND

Multiple pregnancy

Excessive loss of blood

1. Repeated pregnancies and inadequate spacing between pregnancies

2. Hookworm infestation

3.History of menorrhagia

4. Malaria

CHRONIC ILLNESS affecting the general condition of the patients.

36

5.10.2 FACTORS AFFECTING IRON ABSORPTION

DIETARY SOURCES WITH RICH IRON CONTENT;

VEGETARIAN DIET

Green leafy vegetables, spinach, mustard and, fenugreek. In cereals like whole wheat,

bajra, jowar. In pulses like ground nuts, green peas, beans, and other foods like jaggry,

dates.

NON VEGETARIAN DIET

Liver and meat are the good sources of haem iron among non vegetarian foods.

Fish and eggs are containing medium iron content.

FACTORS FAVORING ABSORPTION FACTORS INHIBITING

ABSORPTION

I n organic iron

Organic iron phosphates in egg

yolk, phytates in cereals

Ferrous iron(ironsalts, haem iron)

Ferric iron( non haemiron)

Acids like Hcl, ,citric acid .ascorbic acid

Alkalies, antacids.calcium salts

37

5.10.3 IRON REQUIREMENT DURING PREGNANCY

Requirements Amount (mg)

Expansion of RBC 500

Fetus 200

Placenta & Cord 100

Basal losses 200

Blood loss at delivery 200

Total Need 1200

Amount of iron saved due to amenorrhoea 300 mg. Finally iron requirement during

pregnancy is about 1000mg.

Iron deficiency occurs in three stages:

Stage I: Iron Stores depletion

Stage II: Deficient erythropoiesis

Stage III: Iron deficiency anemia

38

5.10.4 Clinical features

Symptoms

Mildly anemic patients are asymptomatic

• Patients complains of difficulty in breathing, Chest pain,palpitation in severe

anemia.

• Weakness, fatigue, impaired work capacity,

• Giddiness , headache,

• Decreased appetite

• Dyspepsia , anorexia

Signs

• Pallor of skin and mucus membrane.

• Glossitis, Stomatitis

• Koilonychia –Initially there will be brittleness and dryness in the nails later

on, there will be flattening and finally concavity (spoon shaped nails).

• Tachycardia

Investigations

Investigations has to be done to find out

(i) Degree and diagnosis of anemia

(ii) The type of anemia

(iii) Cause of anemia

39

Degree and diagnosis of anemia

Heamoglobin estimation by using acid hematin method (sahli’s heamoglobino meter )

Type of anemia

Peripheral bloods smear using leishmann stain to study the morphology of red blood

cells. Presence of small pale staining cells with variations in size (anisocytosis) and

shape (poikilocytosis) suggestive of microcytic hypochromic anemia. This is the most

common blood picture in iron deficiency.

5.10.5 Haematological indices

(i) Mean corpuscular Volume ( MCV)

= Volumes of packed cells per 1000 milliliters RBC in millions per cmm Normal MCV is 68 cubic microns. If it is more than 90, it indicates macrocytosis

(ii) Mean corpuscular Hb .(MCH)

= HB. in gm per 1000 millimeters of blood RBC in millions per c mm Normal value of MCH is 29.5 picograms in iron deficiency anemia; it will be less than 25 pg.

(iii) Mean Corpuscular Haemoglobin concentration (MCHC) = Hb. In gm per 100ml X 100

Volume of packed cell per 100ml It is normally about 34 %. It denotes the actual heamoglobin concentration in the blood.

It is the most common indices affected in iron deficiency anemia.

40

(iv) Packed cell volume (Haematocrit= Volume of packed cells per 100 milliliters of

blood.

The normal value of PCV is about 40% .

(v) Colour index

= Hb. (percentage of normal )

RBC ( percentage of normal)

The normal value is one. If it is less than, the anemia is hypochromic, and if it is more

than one, then it is hyperchromic.

The typical iron deficiency anemia shows the following blood picture

Hemoglobin is less than 10gms%

PCV less than 30%

Red blood cells –less than 4 millions/cubic mm

MCHC less than 30%

MCH less than 25 pico grams.

MCV less than 70 cubic microns.

41

5.10.6 SPECIFIC INVESTIGATIONS FOR IRON DEFICIENCY

INVESTIGATIONS NORMAL VALUES IRON DEFICIENCY ANEMIA

IN PREGNANCY

Serum iron 60-120 microgram/dl <60 microgram/dl

Total iron binding capacity 300-350microgram/dl >400 microgram/dl

Serum ferritin 15-20microgram/lite <i2 microgram/liter

Saturation percentage of

iron

20-45% <16%

Transferrin receptors 2-4mg/litre Increased

Freeerythrocyte

protoporphyrin

0-35microgram/dl I ncreased

Bone marrow stainable

iron (hemosidderin)

Present Absent

Decrease in the concentration of hemoglobin is relatively late in iron deficiency,before

that iron stores get depleted . Serum iron and total iron binding capacity combined to

give the value of transferrin saturation.Transferrin saturation gets reduced when ever

there is deficient iron supply to the tissues,impairment of erythropoiesis, and iron

dependent tissue enzymes are affected.In the development of iron deficiency serum

ferritin is reduced first .it was the first abnormal laboratory finding.

42

TRANSFERRIN RECEPTOR

It is a relatively new method to assess the cellular iron status. There will be no change in

the serum transferrin receptor concentration in early stages of iron store depletion.

Whenever there is tissue iron deficiency. The serum transferrin receptor concentration

increases in direct propotion to the severity of iron deficiency. This change in transferrin

receptor concentration is first change to appear before the reduction in MCV.When

combined with serum ferritin it will give a complete picture of iron status,Serum ferritin

value denotes iron stores ,and transferrin receptor level depicts tissue iron status.

CAUSES OF ANEMIA

To find out the cause of anemia, history taking will be helpful.

Dietary history regarding Total calorie intake, iron content of the food,presence of

haem iron in the diet, patients knowledge about inhibitors and enhancers of food items in

iron absorption, daily protein content in the diet .Obstetric history birth spacing of short

intervals, multiparous women.

Menstrual history regaring menorrhagia

H/O passing worms in the stools

H/O Malarial fever

H/O Recurrent urinary tract infections

URINE EXAMINATION

Urine routine and Microscopy Urine culture and sensitivity

43

STOOL EXAMINATION

Motion ova cyst and occult blood

HOOK WORM ANEMIA

The worm is a habitual blood sucker,it inhabits in the small intestine particularly jejunum

by attaching to the mucous membrane.The average blood loss per day per worm by the

host,for Ancylostoma duonenale is o-2ml, Nector Americans is 0.03ml.

SERUM PROTEINS

It may show hypo proteinemia

5.11 EFFECT OF ANEMIA ON PREGNANCY

The daily iron requirement during pregnancy is approximately 4mgm which will be

increased to6-8 mgm/day from the 32 weeks of gestation.

ANTEPARTUM PERIOD

Cardiac failure may occur at 30-34 weeks of gestation

Pre term labour risk is increased to 3 fold.

Increased susceptibility to infections

Preeclampsia

DURING LABOUR

Incoordinate Uterine contractions.

Postpartum hemorrhage

Cardiac failure

44

Shock

DURING PUERPERIUM

• Cardiac failure

• Puerperal infection.

• Subinvolution

• Lactational failure

• Chronic ill health

FETAL PROBLEMS

• Small for gestational age

• Preterm babies

• Intra uterine growth restriction

LONG TERM SEQULAE

• Short statured and thin built

• Delayed menarche because of poor iron stores.

• GDM in later life

• H.T. atherosclerosis in later life

5.12 CARE OF ANTENATAL WOMEN WITH ANEMIA

All antenatal women with moderate and severe anemia should be admitted in

the hospital for anemia evaluation and further management. Women with severe anemia

Hb is less than7 gms/dl should be evaluated for cardiac failure and anemia should be

treated according to the gestational age

Ante natal management of anemia depends on the degree ,severity of anemia

,and the gestational age

45

5.13 PHARMACOLOGICAL THERAPY OF ANEMIA

Prophylactic iron supplementation

It can be given as selective prophylaxis or routine basis. In the developed countries,

selective administration of iron is given to women with low or depleted iron stores .A

serum level of ferritin is less than 50gm/l is an indication for selective prophylaxis.

WHO Recommends universal iron supplementation with 60 gm elemental iron daily for

6 months in areas, where the prevalence of iron deficiency is less than 40%,.in areas

where the prevalence is more than 40% the recommendation is to continue 3 months

postpartum.

THERAPEUTIC IRON SUPPLEMENTATION

The oral preparation of iron to treat iron deficiency anemia is100 to200mg elemental

iron. Therapeutic dose of iron should be continued till the hemoglobin becomes normal

and should be followed with prophylactic dose of iron 3 months postpartum. The

reticulocyte count begins to rise within 5-10 days. And hemoglobin should increase

0.8gm/dl /week, .Patients who were not responding to iron therapy should be evaluated

for non compliance,presence of ongoing blood loss,any other infections,other nutrient

deficiency.

The ministry of health, Govt of India now recommends 100 mg of elemental iron and

500 micrograms of folic acid as routine supplementation.

46

PARENTRAL THERAPY

The main advantage with parenteral iron is with the certainity of administration.The

increase in hemoglobin is more or less similar to oral iron 1gm/week.

DOSE OF IRON NEEDED mg=normal Hb –patients Hb X weight in kg X 2.21

Another 1000gm of iron to be added to this for replenishment of iron stores

INDICATIONS FOR PARANTERAL IRON

• Intolerance to oral iron

• Non compliance

• Malabsorption syndromes

• No response to oral iron after 4 weeks of therapy

• Moderate to severe anemia in later weeks of gestation

The available iron preparations are iron dextran,iron sorbitol citrate. The intravenous

iron is associated with the possibility of anaphylactic reactions.Other problems are

tachycardia, hypotension,flushing,and syncope.At the site of infusion, thrombophlebitis

can occur.Oral iron should be stopped for atleast 48 hours before paranteral iron to

prevent iron intoxication.At 14 weeks of gestation ,T. ALBENDAZOLE 400mgm should

be given for deworming.

5.14 .BLOOD TRANSFUSION

It is indicated in the following cases of iron defiency anemia,

• Severe anemia with Hb is less than 7grams at any gestational age

• Moderate anemia ( Hb 7-10gm) patients ,when there is no response iron

therapy,after 36 weeks

47

• Severe ante partum hemorrhage and postpartum hemorrhage Packed cell blood

transfusion is preferred than whole blood transfusion because of less volume

overload, lesser incidence of transfusion reactions. One unit of packed cells raise

the hematocrit by 3 to4% and hemoglobin by 0.8 to1gms.

5.15 INTRAPARTUM MANAGEMENT

Strict asepsis should be maintained to prevent purperal sepsis

Nasal oxygen 5 litres /min to the mother to prevent fetal hypoxia.

Adequate cross matched blood should be kept ready

No fluid overload

Second stage of labour should be cut short by prophylactic outlet forceps to prevent

maternal exhaustion.

Active management of third stage of labour should be followed.

Anticipate post partum hemorrhage and kept everything ready.

In case of PPH, adequate amount of blood should be replaced

5.16 POSTPARTUM MANAGEMENT

During puerperium, strict asepsis should be maintained.close monitoring of pulse rate

,blood pressure should be done , measure ment of hemoglobin in the postnatal period is

mandatory.

There is the possibility of deepvein thrombosis,cardiac failure in the immediate puerperal

period ,it should be watched for and managed appropriately. Contraception Advice

regarding spacing of pregnancies contraceptive pills like progesterone only pill should be

prescribed

48

6. PRE ECLAMPSIA

6.1 DEFINITION;

Preeclampsia is defined as a multisystem disorder of unknown

etiology characterized by development of hypertension to the extent of 140/90 mmHg or

more with proteinuria after 20 weeks of gestation in a previously normotensive and non

proteinuric women.

INCIDENCE

The incidence of preeclampsia varies from5-15%. The incidence in

primigravida is about 10% and multigravida is about 5%

6.2 CLASSIFICATION OF HYPERTENSIVE DISORDERS OF PREGNANCY

NHBPEP 2000

GESTATIONAL HYPERTESION

1)Blood pressure 140/90mmHg or more for the first time in pregnancy after 20 weeks of

gestation.

2)No proteinuria

3)Return of BP to normal with in 12 weeks after delivery

4) Other signs of pre eclampsia like headache, epigastric discomfort,or

thrombocytopenia may be present.Final diagnosis is made only after 3 months of

delivery.

49

PRE ECLAMPSIA

BASIC CRITERIA

• Blood pressure 140/90mmHg or more after 20 weeks of gestation.

• Proteinuria 300mgms or more in 24 hours or persistent 1+ or more in dipstick

random samples

DEFINITIVE CRITERIA

• Blood pressure 160/110mm Hg or more

• Proteinuria 2+ on dipstick or 2 gms in 24 hours sample

• Raised serum creatinine(>1.2mg)

• Thrombocytopenia(platelets <1 lakh)

• Evidence of hemolysis(raised LDH levels)

• Elevated liver enzymes ( raised SGOT and SGPT)

• Symptoms of severe pre eclampsia like persistent headache, cerebral or visual

disturbances, or persistent epigastric pain.

ECLAMPSIA

Development of convulsions in a case of preeclampsia ,in the absence of other causes

of convulsion.

SUPERIMPOSED PREECLAMPSIA

Onset of proteinuria of 300 mg/24 hours or more in a woman who had hypertension

but no proteinuria before 20 weeksgestation. Development of sudden increase in

proteinuria ,hypertension,or thrombocytopenia in a womanwho had hypertension or

proteinuria before 20 weeks of gestation.

50

CHRONIC HYPERTENSION

• A known hypertensive woman becoming pregnant with BP 140/90mmHg or

more before pregnancy or diagnosed before 20 weeks of pregnancyin the absence

of gestational troblastic disease.

• Hypertension diagnosed first after 20 weeks but persisting 12 weeks after

delivery.

6.3 ETIOLOGY

The exact etiology of preeclampsia is not known ,it may be due to multiple risk factors.

Various theories put forward to explain the etiology,

ABNORMAL TROBLASTIC INVASION AND PLACENTAL ISCHEMIA

THEORY;

Preeclampsia occurs in two stages

Stage 1; there is failure of secondary wave of trophoblastic invasion of the spiral

arterioles.and the blood supply to the placenta gets reduced.

Stage 2; the effect of placental ischemia due to generalized vasospasm on the mother and

fetus

GENETIC HYPOTHESIS

Genetic conflict hypothesis by Heigs says that maternal BP is determined by the balance

between the fetal factors increasing BP and maternal factors decrease the BP. The level

of raise in solubleFlt-1 denotes the disease severity.

51

IMMUNOLOGICAL THEORY;

This theory states that preeclampsia arises due to inadequate maternal immune response

to the fetal allograft with vascular damage from circulating immune complexes. The

trophoblasts invasion into the myometrium and decidua is mainly cotrolled by

immunological factors. Regulatory Tcells are responsible for specific immune tolerance

to fetal antigens .Previous exposure to paternal antigens is protective against

preeclampsia ,because of this preeclampsia is more common in primigravida.

6.4 RISK FACTORS FOR PREECLAMPSIA

GENETIC FACTORS

Race and Ethnicity more common in Blacks and Asians

Family history of preeclampsia (mothers and sisters)

PRECONCEPTIONAL FACTORS

Nulliparous women

Women with the age group of less than 19 years

Women with age group of more than 40 years

PARTNER RELATED FACTORS

Donor insemination of sperm

Oocyte donation

Change of male partner

52

PRESENCE OF SPECIFIC UNDERLYING DISORDERS

Chronic hypertension

Renal disease

Obesity

Insulin resistance

Maternal low birth weight

Gestational diabetes

Type I diabetes mellitus

Activated protein C resistance

Protein S deficiency

Antiphospolipid antibodies

Hyper homocysteinemia

Sickle cell disease,sickle cell trait.

PREGNANCY ASSOCIATED RISK FACTORS

Multiple pregnancy

Structural congenital anomalies

Hydrops fetalis

Chromosomal anomalies(trisomy13,triploidy

Hydatidiform moles

Urinary tract infection

53

EXOGENEOUS FACTORS

Smoking(risk reduction)

Stress,work related psychosocial strain

Previous history of preeclampsia

6.5 PATHOGENESIS

KEY FEATURES;

Impaired endo vascular cytotrophoblast invasion in the spiral arterioles

Endothelial cell dysfunction and vasospasm

Exaggerated inflammatory response

PLACENTAL DYSFUNCTION

In normal pregnancy ,the cytotrophoblasts invade the spiral arteies of placenta,and the

elastic ,muscular coats are replaced by fibrinoid material. In the second trimester second

wave of tropoblastic invasion occurs,it coverts the blood supply in to slow resistance

high flow system ,there by it increase the uteroplacental blood flow. The primary

tropoblstic invasion is impaired and second wave of invasion is absent in preeclampsia.It

will result in reduced uteroplacental blood flow.

ENDOTHELIAL CELL DYSFUNCTION

Endothelium is one of the main organ involved in the pathophysiology .There is

imbalance between the prostacylin and thomboxaneA2,impairment of nitric oxide-cylic

guanosine monophospate pathway. This results in relative increase in

thrombaxane,which causes vasoconstriction and platelet aggregation

54

ACTIVATION OF THE COAGULATION SYSTEM

Activation of the platlets and cogulation system by the tissue factor which was released

during endothelial cell dysfunction. It will result in consumption of clotting factors and

platelets resulting in thrombocytopenia,all these changes lead to wide spread multiple

small haemorrhages and fibrin deposition in many organs.

PROANGIOGENIC AND ANTIANGIOGENIC PROTEINS;

Proangiogenic proteins are more during early pregnancy for placental angiogenesis, but

nearing term antiangiogenic factors are more towards the preparation of labour. In the

preeclampsia placenta, messenger RNA for sFlt is upregulated,resuting in increased sFlt

in the circulation . This will cause decrease in the concentration of free VEGF and PLGF

in preeclampsia.Another factor soluble form of endoglin starts to increase 6-10 weeks

before the clinical symptoms of preeclampsia.

6.6 PATHOLOGICAL CHANGES IN ORGANS

PLANCETA

Acute atherosis of spiral arteries ,charecterised by fibrinoid necrosis,macrophages and

mononuclear cell infiltration.

KIDNEY

The main pathology is glomerular endotheliosis,this characterized by swollen endothelial

cells due to fibrin deposition.It is clinically presented as proteinuria. In severe cases

,reduction in the glomerular filtration rate and cretinine clearance may occur ,it will

cause increase in the blood urea and serum creatinine, Acute renal injury can occur due

to acute tubular necrosis.

55

LIVER

Subcapsular haemorrhages and periportal necrosis are the main pathological features in

severe form of preeclampsia.SGOT and SGPT are elevated.Subcapsular haematoma may

stretch the liver capsule and produce epigastic pain which is the imminent symptom of

eclampsia.

BRAIN

Cerebral vasospasm in the main pathology,small cerebral

haemorrhages,thrombosis,fibrinoid necrosis,cerebral edema will occur in

eclampsia.Temporary cortical blindness can rarely occur due to the edema of the

occipital lobe.

EYES

The commonest finding is localized retinal vasospasm. Very rarely retinal detachment

may occur , it usually improve

CARDIOVASCULAR SYSTEM;

The commonest findings are generalized vasospasm,increased peripheral

resistance,reduced central venous pressure and pulmonary wedge pressure.

WATER AND ELECTROLYTES;

There is sodium and water retention, it increases the extracellular fluid volume.It will

result in reduction of intravascular compartment and hemoconcentration.

56

6.7 CLINICAL FEATURES

SYMPTOMS;

Usually signs will precede the symptoms.

Edema and excessive weight gain are the usual symptoms.,

Acute onset of preeclampsia presented as follows

Central nervous system; Headache,mostly in the frontal region or in the occipital region

which was not relieved by analgesics.

Gastro intestinalsystem; 1)Epigastric pain or right upper quadrant pain

2)Nausea and vomiting

Visual symptoms like blurring of vision or dimness of vision,scotoma are usually due to

retinal artery spasm and retinal edema, some times loss of vision ,but it usually regains

with in 4-6 weeks after delivery.

Renal symptoms like oliguria haematuria rarely anuria

Pulmonary symptoms like difficulty in breathing due to pulmonary edema or cardiogenic

edema.

SIGNS;

Abnormal weight gain ; Rapid gain in weight may be the first sign in some patients

,weight gaining of more than 1Kg/week or more than 3Kg in a month is significant.

Hypertension; The diastolic blood pressure begins to rise before the systolic pressure

Edema; edema of the non dependent parts usually not relieved by rest, generalized

edema indicates imminent sign for eclampsia.

Pulmonary edema ,because of low oncotic pressure and leaky capillaries.

57

Visual examination reveals retinal artery spasm,retinal hemorrhages,cotton wool

exudates,and papilledema occurs in severe cases.

Abdominal examination shows hepatic enlargement, epigastric tenderness,ascites,

scanty liquor.

6.8 INVESTIGATIONS

(1)Renal function tests;

Urine for protein,pus cells,red cell casts.

24 hours urinary protein

Serum uric acid

Blood urea and serum creatinine

(2)Liver function tests;

SGOT and SGPTwill be elevated

Bilirubin will be elevated

(3)Haematological investigations

Haematocrit,

Evidence of hemolysis on peripheral smear

Thombocytopenia

Lactic dehydrogenase will be elevated

Prolongation of clotting time,APTT,and prothombin time Clot retraction time

4)FUNDUS EXAMINATION ;

(There will be retinal arteriolar vasospasm,and retinal edema initially,it may extend to

cotton wool exudates ,retinal haemorrhages and retinal detachment will rarely occur.

58

6.10 MANAGEMENT

PRIMARY PREVENTION;

PREPREGNANCY;

Women who are overweight or obese advised regarding the benefit of maintaining the

ideal body weight before conception to prevent the incidence of preeclampsia.

First trimester folic acid supplementation and B12 supplementation not only reduce the

neural tube defects and also preeclampsia risk is reduced to 50%

Women with chronic hypertension should be advised regarding control of their BP

before conception. Women with pregestational diabetes should be advised to complete

their family before the development of vascular complications.

SECONDARY PREVENTION

Recurrent risk of preeclampsia in subsequent pregnancies is about 14%, but in women

with prior early onset preeclampsia and chronic hypertension the recurrence is

about50%.

Antiplatelet agents ; Low dose aspirin 50-150mg/day was prescribed ,the mechanism of

action is aspirin will inhibit thromboxane A2 synthesis there by altering the balance

between prostacylin and thromboxaneA2, thus it will prevent the development of

preeclampsia.

Calcium supplementation; The mechanism of action of calcium is to reduce the

parathyroid hormone release and intracellular calcium, this leads to reduce the smooth

muscle reactivity and vasodilatation will occur. Extracellular calcium ion

59

concentrations is the factor involved in the production of endothelial nitric oxide. The

decreased production of nitric acid is implicated in the pathophysiology of preeclampsia.

Heparin or lowmolecular weight heparin; It can be used in women with renal disease and

thrombophilia. Anti oxidants vitamins,Protein and salt restriction has no role in the

prevention of preeclampsia.

6.10 MILD PREECLAMPSIA

OBJECTIVES

• To control the hypertension and prevents its progression in to severe

preeclampsia.

• To prevent the maternal complications like cerebro vascular accidents,renal

failure ,placental abruption,and pulmonary edema.

• To prevent eclampsia

• Delivery of a healthy baby with least trauma.

• Complete restoration of maternal health.

Ideally all cases of preeclampsia should be admitted for evalution and treatment.

Some cases of uncomplicated preeclampsia ,remote from term should be advised home

management, they were instructed regarding the signs and symptoms of imminent

eclampsia,regular antenatal visits twice in a week

60

HOSPITAL MANAGEMENT

Rest in the left lateral position,

ANTIHYPERTENSIVE THERAPY

Anti hypertensive drugs are prescribed when the blood pressure is more than 140/90

mmHg.

Labetalol is a safe and effective drug to control hypertension in the pregnant women.It is

a non selective beta blocker with some alpha blocking property. The dose is 100-200 mg

thrice daily.( maximum of 1200mg)

Nifidipine is a calcium channel blocker the dose is 10-20 mg tds(maximum 120mg).

Alpha methyl dopa 250-500mg tds ,it is a central and peripherally acting anti adrenergic

drug.

MATERNAL MONITORING

• Every 4th hourly BP moitoring

• Daily weight chart

• Urine for proteinuria

• Presence of facial edema and abdominal wall edema

• Symptoms of imminent eclampsia like persistent frontal or occipital

headache,blurring of vision,and epigatric pain

• Intake output chart

• Hemoglobin and platelet count twice in a week

• Renal and liver function tests twice in a week

61

FETAL MONITORING

• Daily fetal movement count

• Non stress test twice a week

• If non reactive NST, biophysical profile

• Ultra sound evaluation of fetal growth every two weeks

INDICATION FOR DELIVERY

Maternal indication;

• Persistent rise in blood pressure ,increase in proteinuria

• Development of imminent signs for eclampsia

• Progreesive decline in the platelet count

• Elevated liver enzymes

• Evidence of hemolysis

Fetal indication;

• Gestational age 37 completed weeks

• Severe oligo hydraminos

• Severe intra uterine growth restriction

• Non reactive NST with abnormal biophysical profile

MANAGEMENT OF LABOUR

INDUCTION OF LABOUR;

At 37 completed weeks of gestation , termination of pregnancy is desirable. If the cervix

is favorable Bishops score more than 6 ,low rupture of membranes followed by

62

syntocinon acceleration shoud be done. If the cervix is unfavourable ,Bishops score less

than 6, prostaglandin E2 induction can be done

INTRAPARTUM MANAGEMENT;

Monitoring of maternal pulse,blood pressure, respiration every 3o minutes

Hourly Urine output, intake chart

Continuous electronic fetal heart rate monitoring or intermittent auscultation of fetal

heart once in 15 minutes during 1st stage of labour, and every 5 minutes during second

stage of labour.

Vaginal delivery is preferred,because operative delivery is associated with more post

operative morbidities.Caesarean section should be performed onlyfor obstetric

indications.Active management of third stage of labour should be followed to reduce the

postpartum blood loss.

6.11 SEVERE PREECLAMPSIA

All severe preeclampia patients should be admitted in the tertiary care hospital. Anti

Hyper tensive therapy should be started immediately,Propylactic anti convulsant regimen

should be given .The goal of anti hypertensives is to keep the diastolic BP between 90-

100 to prevent complications

63

6.11.1 MATERNAL MONITORING

• Bed rest in the left lateral position

• BP monitoring second hourly

• Urine albumin twice a day

• Liver function test Renal function tests on alternate days

• Corticosteroid administration (if the gestational age is less than 34 weeks)

6.11.2 FETAL MONITORING

• Daily fetal movement count

• Daily non stress test

• Ultra sound for liquor adequacy once in two days

• Ultra sound biweekly for assessing fetal growth

6.11.3 INDICATIONS FOR DELIVERY

Persistent rise in BP > 160/110 mm of Hg on women who is receiving anti hypertensives

Oliguria urine output of less than 500ml or less in 24 hours

Thrombocytopenia platelet count less than 50,000

Serum creatinine is raised

Severe head ache or visual disturbances

Any alteration in the coagulation profile

HELLP Syndrome

Placental abruption

Pulmonary edema

Eclampsia

64

Severe IUGR with oligo hydraminos

Doppler parameter alterations CPR <1,reversal of umbilical artery blood flow

Intra uterine death

INDUCTON OF LABOUR

Termination of pregnancy is the treatment for severe preeclampsia, it should be

terminated at 36 weeks .Depending upon the Bishops score we have to induce labour , if

the cervix is favourable , ARM. Oxytocin acceleration shold be done . If the cervix is

unfavourable PGE2 gel to be kept .

INTRAPARTUM MANAGEMENT

Vaginal delivery is preferred . Caesarean section should be performed only for obstetric

indications .Partogram should be maintained.careful monitoring of the fetal heart

because most of the babies are having growth restriction ,they cannot withstand the stress

of labour,more likely to get asphyxiated.Intake output chart should be strictly

monitored.Urine output should be measured hourly.prophylactic magnesium sulphate

regimen should be continued for24 hours.

POSTPARTUM

Active management of third stage of labour should be followed to prevent postpartum

hemorrhage.Anti hypertensives should be continued in the post partum period.Close

observation of severe preeclamptic patients is must ,because of redistribution of blood

flow , they may develop pulmonary edema.

65

6.11.4 COMPLICATIONS OF SEVERE PREECLAMPSIA

MATERNAL COMPLICATIONS

• Elampsia

• Accidental hemorrhage particularly placental abruption

• Cerebral hemorrhage

• Renal failure mostly acute renal injury

• Cardiac failure

• Coagulation failure DIC

• Preterm labour

• HELLP Syndrome

• Visual complications

• Post partum hemorrhage

• Pulmonary edema

FETAL COMPLICATIONS

• Intrauterine growth restriction

• Preterm babies because of induction of labour

• Intra uterine death

• Intrapartum asphyxia

After discharge patient should be followed for 6 weeks , We have to advise the patient to

continue antihypertensive therapy., weekly checkup in the postpartum period.If the blood

pressure is not coming down after six weeks , we have to evaluate the patient for chronic

hypertension.

66

7.AIM OF THE STUDY

• To find out the incidence of preeclampsia in mild, moderate, and severe anemia.

• To analyse the synergistic effect of anemia with preeclampsia in pregnancy

associated Morbidity and Mortality.

8. MATERIALS AND METHODS

This prospective observational study was carried out at Govt.KasturbaGandhi

Hospital for women and children,Madras medical college, Chennai,during the period of

December 2012 to December 2013 on 200 patients. The study was approved by the

hospital ethical committee.

8.1 INCLUSION CRITERIA

All antenatal women diagnosed to be having anemia with singleton pregnancy after 20

weeks of gestation,

8.2 EXCLUSION CRITERIA

• Multiple pregnancies

• Pre gestational diseases like renal disease, diabetes mellitus, autoimmune disease,

• Known hypertensive

• Immunocompromised individuals

• Gestational age less than 20 weeks

• Other hemolytic anemia and heritaryanemia

67

8.3 METHODS

Pregnant women attending the antenatal out patient department and labour ward in

Govt.Kasturba Gandhi Hospital with hemoglobin value less than 11gms and after 20

weeks of gestation were selected for the study.The patients who selected were explained

about the study and their consent obtained.

The base line data recored at the first antenatal visit included the following;

• Maternal age

• Gestational age at present

• Parity status

• Socio economic status

• Associated pregnancy complications

• Previous pregnancy

• Interpregnancy interval

• Family history of preeclampsia

• Maternal weight

• H/o smoking

• Blood pressure

• Hemoglobin value at first visit

• Urine albumin

After recording the base line data, patients with moderate and severe anemia were

advised admission for anemia evaluation and treatment .In these patients the incidence of

preeclampsia at the time of admission were calculated. The patients with preeclampsia

were admitted and the following investigations were carried out.

68

• Complete haemogram with peripheral smear

• Blood sugar, urea ,serum creatinine,

• Liver function test

• Urine analysis

• 24 hours urinary protein

• Fundus examination

• ECG In all leads

The selected patients were monitored and followed till delivery. According to the

severity of anemia and the gestational age, patients were treated with oral iron, parenteral

iron,or by blood transfusion. All preeclampsia patients were classified in to mild and

severe type, according to the severity gestational age, they were treated with

antihypertensives, prophylactic anticonvulsant regimen,and termination of pregnancy.

They were followed through the antepartum,intrapartum,and post partum period . Finally

I analysed the mode of delivery,pregnancy complications, maternal outcome ,morbidity

and mortality and perinatal outcome.

8.4 STATISTICAL METHODS

The statistical methods employed in the study were The Excel were used for data

entry,and SPSS software were used for analysis

69

MEAN

CHI SQUARE TEST

X2=∑ (Oi-Ei)2

Ei

Where Oi is observed frequency and Ei is expected frequency, with (n-1) difference.

SIGINIFICANT P VALUE

If the P value is 0.000 to 0.010 it imply Significant at 1 level (Highly Significant)

If the P value is 0.011 to 0.050 it imply Significant at 5 levels (Significant)

If the P value is 0.051 to 1.000 it imply Not Significant at 5 level (Not Significant)

70

9.RESULTS AND ANALYSIS

This prospective observational study was conducted at Govt. Kasturba Gandhi Hospital

during the period of December 2012 to December2013.

Sample of the study was 200 cases.

71

AGEDISTRIBUTION TABLE 1

Frequency Percent Valid < 19 27 13.5 20-29 144 72.0 30-35 28 14.0 > 35 1 .5

Most of the patients in the study population were in the age group of 20 to 29

years.followed by age group of 30-35 years.

13.5% of the patients were in age group less than 19 years.

The youngest age in the sample was 14 years, and the eldest was 36 years.

AGE DISTRIBUTION

<19

20-29

30-35

>35

72

DISTRIBUTION OF GRAVIDITY TABLE 2

Frequency Percent Primi 89 44.5 Second

Gravida 97 48.5

Third Gravida

14 7.0

Most of the cases were in second gravida .48.5% of cases were in second gravida.

44.5% of cases were in primigravida.

7% of cases were in third gravida.

DISTRIBUTION OF GRAVIDITY

PRIMI

G2

G3

73

DISTRIBUTION OF SOCIO ECONOMIC CLASS TABLE 3

Frequency Percent IV

155 77.5

V 45 22.5

Most of the cases were in lower socioeconomic groups.

77.5% of cases were in class IV socio economic group.

22.5% of cases were in class V socioeconomic group.

DISTRIBUTION OF SOCIOECONOMIC CLASS

74

DISTRIBUTION OF BOOKING STATUS TABLE 4

Frequency Percent B

199 99.5

UB 1 .5

99.5% were booked cases

0.5% was unbooked case . there was only one case unbooked among 200 study

population.

Booked status

75

REFERRAL STATUS TABLE-5

Frequency Percent Yes

55 27.5

No 145 72.5

27.5% of cases were referred from near by govt.hospitals, because of associated

pregnancy complications.

76

LITERACY STATUS TABLE 6

Frequency Percent Illiterate 15 7.5 Primary 35 17.5 Middle 44 22.0 High

School 79 39.5

HSc 22 11.0

Graduate 5

2.5

39.5%of cases were studied up to high school level.

7.5% were illiterate.

22% of cases were studied at primary level.

11% of cases were studied up to higher secondary level.

5% of cases were graduates.

77

DISTRIBUTION OF MATERNAL WEIGHT

Frequency Percent < 50 5 2.5

50-60 80 40.0 60-70 83 41.5 > 70 32 16.0

Most of the cases were in the weight group of 60 to 70 kg constitutes about 41.5%.

2.5%of the cases were in the weight range of under 50 kg.

40% of the cases were in the weight range of 50 to60 kg.

16% of cases were in the weight range of above 70 kg.

78

DISTRIBUTION OF GESTATIONAL AGE TABLE 8

Frequency Percent TERM

153 76.5

36-38 15 7.5 34-36 25 12.5 28-34 5 2.5 < 28 2 1.0

76.5% Of the cases were in the term gestation.

12.5% of the cases were in the 34 to 36 weeks of gestation.

7.5% of the cases were in the 36 to 38 weeks of gestation.

2.5% of cases were in the 28 to 34 weeks of gestation.

1% of cases were in the<28 weeks of gestation.

79

DISTRIBUTION OF SEVERITY OF ANEMIA TABLE 9

Frequency Percent

10-11 12 6.0

7-10 166 83.0

< 7.0 22 11.0

83% of the cases were in the moderate anemia.(Hb 7.5-10gms).

11% of the cases were in the severe anemia(Hb < 7.0 gms).

6% of the cases were in the mild anemia (Hb 10-11gms).

SEVERITY OF ANEMIA

10-11gms

7-10gms

<7gms

80

DISTRIBUTION OF PERIPHERAL SMEAR TABLE 10

Frequency Percent Microcytic hypo chromic 170 85.0

Normal 30 15.0

Total 200 100.0

DISTRIBUTION OF PERIPHERAL SMEAR

Microcytic hypochromic

Normocytic normochromic

81

DISTRIBUTION OF PLATELET COUNT - TABLE 11

Frequency Percent > 100000 195 97.5

100000-50000 4 2.0 < 50000 1 .5

Most of the cases were having the platelet count above 1 lakh count, it consistutes about

97.5%.

2% of cases were having the platelet count between 1 lakh-50,000.

0.5% of cases were having thrombocytopenia( plate count <50.000).

82

DISTRIBUTION OF SEVERITY OF BLOOD PRESSURE TABLE 12

Frequency Percent 120/80

128 64.0

DBP 90

19 9.5

DBP 100

30 15.0

>160/110 23 11.5

64% of the cases were in the normotensive group in the blood pressure range of

(120/80)mmHg.

11.5% of the cases were in the blood pressure range of >160/110mmHg.

15% of the cases were in the diastolic blood pressure 100 .9.5%of the cases were in the

diastolic blood pressure 90

83

DISTRIBUTION OF URINE ALBUMIN TABLE 13

Frequency Percent

Nil 150 75.0

Trace 17 8..5

1+ 11 5.5

2+ 13 6.5

3+ 6 3

4+ 3 1.5

75% of the cases were having urine albumin nil.

8.5% of the cases were having urine albumin trace.

5.5% of the cases were having urine albumin1+.

6.5% of the cases were having urine albumin2+.

3% of the cases were having urine albumin3+.

1.5% of the cases were having urine albumin4+

84

85

DISTRIBUTION OF 24 HOURS URINARY PROTIEN- TABLE 14

Frequency Percent Not done 130 65

< 300 mg 33 16.5

300 mg - 1 gm 14 7

1-3 gm 23 11.5

Among the 2oo study population,24 hours urinary protein was not for 130 cases because

their urine albumin is nil throught the study period.

16.5% of the cases were having 24 hours urinary protein less than 300mgs.

7% of the cases were having 24 hours urinary protein in the range of 300mgs to1gms.

11.5%of the cases were having 24 hours urinary protein 1gm to 3gms.

86

ONSET OF LABOUR TABLE 15

FREQUENCY PERCENTAGE

ELECTIVE LSCS 13 6.5

SPONTANEOUS ONSET 146 73

INDUCTION OF LABOUR 41 20.5

73% of the cases were developed spontaneous onset of labour , followed by

syntocinon acceleration.

6.5% of cases were posted for elective LSCS.

20.5% of the cases were undervent induction of labour.

87

MODE OF DELIVERY TABLE 16

Frequency Percent Labour natural 92 46.0 Primary LSCS 63 31.5 Breech 4 2.0 Rpt LSCS 15 7.5 Instrumental 8 4.0 Rpt LSCS with ST 10 5.0 Rpt LSCS with CuT 4 2.0 VBAC 1 .5 SpontaneousExpulsion 3 1.5

46% of the cases were delivered labour naturally.

Primary LSCS constitutes about 31.5%.

Assisted breech delivery constitutes about2%

Repeated LSCS delivery constitutes about 14.5%.

Instrumental delivery constitutes about 4%.

Vaginal birth after caesarean constitutes about 0.5%

Spontaneous expulsion of the fetus was occurring in 1.5%.

MODE OF DELIVERY

Labour natural

Primary LSCS

Breech

Repeat lscs

Instrumental

VBAC

Spont.expulsion

88

MATERNAL OUTCOME TABLE 17

Complications Frequency Percentage ATONIC PPH 12 6 WOUND INFECTION 4 2 PULMONARY EDEMA 3 1.5 DEATH 1 0.5 HELP SYNSDROME DIVC 1 0.5 ABRUPTIO PLACENTA 2 1 ACUTE RENAL INJURY ECLAMPSIA 4 2

AtonicPPH occurs in 6% of the study population.Pulmonary edema occurred in 1.5%,

Death occurred in one case in the studypopulation.Both HELLP and DIVC occurred in

one case 0.5%.Abruptio placenta occurred in 1%.Eclampsia occurred in 2% of the cases.

89

FETAL OUTCOME - TABLE 18

Frequency Percent Term

155 77.5

Preterm

15 7.5

IUGR 24

12.0

Still Birth 6 3.0

77.5% of the babies were term babies.

Preterm babies constitutes about 7.5%.

IUGR babies constitutes about 12%.

3% of the babies were still born.

90

BIRTH WEIGHT TABLE 19

KG FREQUENCY PERCENT

<1.5 7 3.5

1.6 – 2.0 17 8.5

2 – 2.5 63 31.5

2.5 – 3.0 62 31

3.0 – 4.0 51 25.5

31% of the babies born were in the birth weight 2.5 to 3Kg.

31.5% of the babies born were in the birthweight 2to 2.5.kg.

25.5% of the babies born were in the birth weight 3to 4Kg.

8.5%of the babies born were in the birth weight 1.6 to2Kg.

3.5% of the babies born were in the birthweight <1.5 Kg.

.

BIRTH WEIGHT

<1.5KG

1.6-2KG

2-2.5KG

2.5-3KG

3-4 KG

91

BLOOD TRANSUSION TABLE 20

Frequency Percent Yes

75 37.5

No 125 62.5

Among the 200 sample population , blood transfusion was given for 37.5%.

92

CROSS TABLE HEMOGLOBIN AND BLOOD PRESSURE TABLE 21

HEMOGLOBIN

Gms/dl

BLOOD PRESSURE mm Hg

120/80 DBP 90 DBP100 >160/110

10-11 10 2 0 0

7-10 112 15 24 15

<7 6 2 6 8

FREQUENCY 128 19 30 23

PERCENT 64% 9.5% 15% 11.5%

Chi-Square Tests

Value df Asymp. Sig. (2-

sided) Pearson Chi-Square 24.465(a) 6 .000

Likelihood Ratio 24.034 6 .001 Linear-by-Linear Association

20.547 1 .000

This study showed the incidence of preeclampsia increases with the severity of anemia

,the p value is .000 which was highly significant.

93

Heamoglobin

< 7. 7-1010-11

Count

120

100

80

60

40

20

0

BP

120/80

DBP 90

DBP 100

>160/110

94

CROSS TABLE MATERNAL OUTCOME AND BP TABLE 22

COMPLICATIONS

FREQUENCY

BLOOD PRESSURE mmHg

120/80

DBP90

DBP100

>160/110

1.ATONIC PPH 12 7 1 4 0

2.WOUND INFECTION 4 2 0 2 0

3.PULMONARY EDEMA 3 1 1 0 1

4.DEATH 1 0 0 0 1

5.HELLP SYNDROME&DIVC 1 0 0 1 0

6.ABRUPTIOPLACENTA 2 0 1 1 0

7.ECLAMPSIA 4 0 0 2 2

Chi-Square Tests

Value df Asymp. Sig.

(2-sided) Pearson Chi-Square 60.882(a) 30 .001 Likelihood Ratio 44.083 30 .047 Linear-by-Linear Association 9.644 1 .002

N of Valid Cases 200

The cross table relates the maternal outcome with the severity of blood pressure, which

was significant with the p value of0.001.

95

10. DISCUSSION

This prospective observational study was conducted in Govt. KasturbaGandhi hospital

during the period of December 2012 to December2013. To find out the incidence of

preeclampsia in 200 antenatal anemic mothers and assessing the maternal morbidity and

mortality in anemia associated preeclampsia.

TABLE 1

Most of the patients in the study population were in the age group of 20 to 29

years, It constitutes about 72%

This is consistent with the study conducted by Emre Karashin at Gilbane Military

Medical Academy during the period 2006, showed that the mean age of anemic mothers

was 28.3 years.

TABLE 2

DISTRIBUTION OF GRAVIDA

Most of the cases were in the second gravida 48.5%.

A Retrospective cohort study conducted by Ram Hari Ghimire at Nepal to study the

association between maternal and perinatal complications during the period of April

2011- April 2012 stated that anemia was more common in multigravida ,that study

consistuted 6o% of the cases were multigravida. Women with their last child birth with

in 1 year 6 month developed moderate anemia(7.2%) and severe anemia (31.8 %) in the

study population.The estimated p value is .010 which was significant.

96

TABLE 3

In this study, all the patients were belonging to lower socioeconomic class. Of these

77.5% were in the class IV socio economic status.

A Multi Center Cross sectional study conducted at Kualalampur Malaysia Clinal

Research Center, by Jamaiyah Haniff during the period March 2005 stated that anemia

was more common in the lower socioeconomic class 3 and 4 constituted about 56%..

TABLE 4 & 5;

In this study, most of the cases about 99.5% were booked. Among these booked cases

only 70% were booked in our hospital.

27.5% of the patients were referred from nearby Primary health center , Government

hospitals and private hospitals for Institutional management.

TABLE 6

EDUCATIONAL STATUS;

In this study , only 7.5% of the patients are illiterate.39.5% of the patients were studied

up to high school,17% of the patients were studied up to primary school.But this was not

correlate with other studies stated that anemia was more prevalent among the illiterate .

This study was consistent with the Multicenter Cross sectional study at Malaysia during

the period March 2005 showed 61.2% of women were studied up to secondary level.

97

TABLE 7:

MATERNAL WEIGHT

40% Of the patients were in the weight range 50 to 60 kg, 41.5% of the patients were in

the weight range of 60- 70 kg. 16% of the patients were in weight group above 70kg.

This study was found that there was no significant association between maternal weight

and anemia.

A retrospective population based study conducted by AK Mach , JL Kornosky to study

the association between obesity subtypes and the risk of early and late onset

preeclampsia, the results showed that increased BMI and rate of increase in weight gain

increased the incidence of preeclampsia.

The women weighing more than 70 kg were developed preeclampsia (50%). There was

significant association between maternal excessive weight and preeclampsia, the p value

was0.000 which was highly significant.

TABLE -8

DISTRIBUTION OF GESTATIONAL AGE AMONG THE STUDY POPULATION;

76.5% of the patients were in term gestation, this study was correlate with other studies

that anemia was more prevalent during the third trimester. A prospective observational

study was conducted by Nesa Asnafi, Saeed sina at Yahyanejud Gynaecology and

obstetric clinic during the period of March 2000 to August 2000 to find out the

prevalence o anemia in pregnant women and its relationship to mothers age and

gestational age stated that anemia was more common in the third trimester than first and

second trimester (p value was < 0.05).

98

A prospective observational study was conducted at The health center Tuzla during the

period Jan2009 to 2010 by Lejla Mesalic to to find out the prevalence of anemia per

each trimester as well as the correlation between anemia parameters and gestational age

stated that the average value of haematocrit in the third trimesterwere significantly lower

than the firstand second trimester , the p value was ( 0.0008).

TABLE 9

SEVERITY OF ANEMIA

In this study 83% of the patients were in the moderate anemia with Hb 7.to 10 gms. 11%

of the patients were in the severe anemia with H b less than7grams. This study was

correlated with the descriptive case study at Karnataka by R. G. Viveki during the

period of March 2010 to July 2010 showed that 82.9% of the study population were

mildly anemic, 50% were moderatively anemic and 7% were severely anemic.

A Hospital based Record study was conducted at the tertiary hospital in Pune by Pankaj

kumar during the period of July 2011 to August 2011 showed that 44.4% of the cases

were moderately anemic, 2% of the cases were severely anemic and 53.96% of the

cases were mildly anemic.

TABLE 11

PLATELET COUNT

Most of the cases were having the platelet count above 1 lakh count, it consistutes about

97.5%. 2% of cases were having the platelet count between 1 lakh-50,000. 0.5% of cases

were having thrombocytopenia (plate count <50.000). There was significant association

between platelet count and severe preeclampsia.

99

TABLE 12

DISTRIBUTION OF SEVERITY OF BLOOD PRESSURE

This study was showed that 64% of the cases were in the normotensive group in the

blood pressure range of (120/80)mmHg. 11.5% of the cases were in the blood pressure

range of >160/110mmHg. 15% of the cases were in the diastolic blood pressure 100.

In India the incidence of pre eclampsia was about 8 to 10 % of all pregnancies. This

study showed the incidence of preeclampsia was about 18.5%, and the gestational

hypertension consistuted about 17.5% in anemia complicating pregnancy.23%of cases

were received antihypertensive drugs, 13.5%of cases were treated with Mg so4 regimen.

A retrospective cross sectional study was conducted at Anand district Gujarat during the

period of Febuary 2007 – May 2007 by Punam .D. Sachdeva , B.G. Patel to find out the

incidence and management of pregnancy induced hypertension showed that the

incidence of pregnancy induced hypertension was 14.7% .

TABLE 13 AND 14

URINE ALBUMIN

In this study 6.5% of the patients were having 2+ urine albumin. 3% of the patients were

having 3+ urine albumins. 1.5 % of the patients were having 4+ urine albumin.

24 HOURS URINARY PROTEIN

16.5% of the cases were having 24 hours urinary protein less than 300mgs.

7% of the cases were having 24 hours urinary protein in the range of 300mgs to1gms.

11.5%of the cases were having 24 hours urinary protein 1gm to 3gms.

100

Only 10% of the patients were having significant protienuria by using salphosalicylic

method for estimating urinary protein.By comparing it with 24 hours urinary protein,

18.5% of the cases were found to be having significant proteinuria.

TABLE15

ONSET OF LABOUR

In this study ,73% of the patients were having spontaneous onset of labour, which was

accelerated by low rupture of membranes and oxytocin acceleration.

20.5% of the patients undervent induction of labour using prostaglandinE2 gel.,of these,

5% of the patients were induced for postdatism,11.5% of the patients were induced

because of preeclampsia. 2% were induced for imminent eclampsia, 2% were induced

for oligohydraminos.

TABLE16

MODE OF DELIVERY

46% of the cases were delivered labour naturally .Primary LSCS constitutes about

31.5%.

Assisted breech delivery constitutes about2% Repeated LSCS delivery constitutes about

14.5%.

Instrumental delivery constitutes about 4%. Vaginal birth after caesarean constitutes

about 0.5% .Spontaneous expulsion of the fetus were occurring in 1.5%.

INDICATION FOR PRIMARY LSCS

Fetal distress consistuted about 15.5%, Cephalo pelvic disproportion consistuted about

6.5%,Failed induction -3.5%, Severe oligohydraminos-3%, Preeclampsia-2%, In anemia

101

associated preeclamptic patients , 8% were delivered labour naturally,Primary LSCS -

12.5%, Repeat LSCS -3%.

Of these preeclamptic anemic patients, Indication for primary LSCS were fetal distress

in 4.5%, failed induction-2.5%,severe oligohydraminos1.5%,preeclampsia -2%,

Cephalopelvic disproportion-2%

This was comparable with the study conducted by Vitthal.G.Kuchae , Sunny .K.Kohalae

at Indira Gandhi Memorable hospital during the period July2009-Febuary2010 showed

that in preeclamptic patients 34.24% had normal vaginal delivery.65.5% had caesarean

section.

TABLE17

MATERNAL OUTCOME

AtonicPPH occurs in 6% of the study population.Pulmonary edema occurred in 1.5%,

Death occurred in one case in the studypopulation.Both HELLP and DIVC occurred in

one case 0.5%.Abruptio placenta occurred in 1%.Eclampsia occurred in 2% of the cases.

The comparison of maternal outcomes with anemia complicating patients and anemia

associated with preeclamptic patients were atonic postpartum hemorrhage in anemic4%

and preeclampsia associated patients -2%, post operative wound infection1% in the both

groups, pulmonary edema 1% in anemic patients,0.5% in preeclamptic patients,Death

occurs in one patient among the study population the cause of death was severe

preeclampsia associated with pulmonary edema and severe anemia.HELLP syndrome

occurs in one patient we saved the patient with l8 units of fresh frozen plasma.Abruptio

102

placentae 0.5% in both the groups.Among the eclampsia 3 patients had antepartum

eclampsia and one patient had postpartum eclampsia.

This study was correlated with the descriptive study conducted at J. Ayub Medical

college Abbottabad by Riaz, S.Habib during the period of Jan2010-Dec2010 among the

100 patients with pregnancy induced hypertension showed the following Placental

abruption occurred in 4%.pulmonary edema in 2%,HELLPsyndrome in 5%, ecclampsia

in3%,1 maternal death.

TABLE 18 AND19

FETAL OUTCOME AND BIRTH WEIGHT OF THE BABIES

77.5% of the babies were term babies.Preterm babies constitutes about 7.5%. IUGR

babies constitutes about 12%.3% of the babies were dead 1.5% intrauterine .1.5%

perinatal death. 31% of the babies born were in the birth weight 2.5 to 3Kg.31.5% of the

babies born were in the birthweight 2to 2.5.kg.25.5% of the babies born were in the birth

weight 3to 4Kg. 8.5%of the babies born were in the birth weight 1.6 to2Kg.3.5% of the

babies born were in the birthweight <1.5 Kg.

This study was compared with a retrospective cohort study at Nobel medical college

Nepal by Ram Hari Ghimire, SitaGhimire during the period of April 2011 to April2012

to find out the association between anemia and perinatal and maternal complications

showed the following, Intra uterine death occurred in 6%, Preterm babies about 9.9% ,

IUGR babies -8.6%,Low birth babies -22%, Perinatal death 11%.

In this study , 72% of the patient had taken iron and folic acid,22% of the patient had

treated with parenteral iron preparations, 37.5% of the patient received blood

103

transfusion,2.5% of the patients had received fresh frozen plasma along with blood

transfusion.

TABLE 21

STATISTICAL ANALYSIS BETWEEN HEMOGLOBIN AND BLOOD PRESSURE

This study showed the association between anemia and the preeclampsia, anemic

patients were more prone to develop preeclampsia due to associated hypo proteinemia.

More severe the anemia, greater the chance to get preeclampsia. Incidence of

preeclampsia in the study was 18.5%, the p value shows .000 highly significant,

This study was co relate with the study conducted by J.J.Zhang, J. Grewal,J.P.souza,

they used the data from WHO Global Surveyfor maternal and perinatal health collected

in hospitals from2007-2008 to analyse the several types of anemia were risk factors for

developing hypertensive disorders during pregnancy in the developing countries,the

results showed that multiparous women with severe anemia were increased chance to get

gestational hypertension( ODDS RATIO 1.58)confidence interval of( 1.15-2.19).

Nulliparous women with severe anemia were having significant correlation with

preeclampsia(OR)3.55; 95% CI2.87-4.41, Multiparous women with severe anemia were

having increasedrisk to develop preeclampsia (OR;3.94;95% CI 3.05-5.09).Cochrane

case control trial titled as Interrelationship between iron deficiency anemia and

impaired renal function in toxemia of pregnancy by Fernandez.G, Diez EM, Velaquez

N, conducted during1976, showed that increased coexistence of preeclampsia in anemic

patients.

104

A retrospective case control study conducted at Sudan by Abdel Aziem A Ali showed

that the corrected risk of preeclampsia increased only in severe anemia

(OR=3.6,p=0.007)

Disscussion

NEAR MISS CASES IN THE STUDY

There were three cases found to be near miss throughout the study period.

CASE 1

23 years old primi with term gestation , referred from Koovathur PHC, admitted with

complaints of epistaxis and hemoptysis , we diagnosed her, as a case of severe

preeclampsia with severe anemia . Her hemoglobin was 7gms and platelet count was 1

lakh twenty thousand, we had treated her with 8 units of fresh frozen plasma,Mgso4

regimen was started, cerviprime gel induction was done, patient was delivered labour

naturally after 8 hours of induction, Active management of third stage of labour was

followed, 2 hours later she developed pulmonary edema, we treated her with frusemide

and connected to the continuous positive pressure ventilation. Her Hb was 6 gms in the

postnatal period we transfused with two units of packed cell transfusion.

CASE 2

20 years primi with 34 weeks of gestation , referred from chemmancherry PHC, as

severe anemia with preeclampsia admitted with labour pains,we diagnosed her as a case

of severe preeclampsia associated with severe anemia (Hb 6.7 gms , platelet count

normal) patient was in active stage of labour , she delivered a preterm baby with in 2

hours of admission.we treated her with antihypertensives and Mgso4 regimen, suddenly

she developed post partum eclampsia and became unconscious , we connected the

patient to the ventilator, strict fluid management, intravenous labetalol was given ,After

105

36 hours, patient was slowly weaned off from artificial respiration.After giving

frusemide we transfused 3 units of packed cell transfusion once in 5 days in the

postnatal period.

CASE 3

28 years primi with term gestation, known case of gestational hypertension with on

T.Labetalol for the past one month ,admitted with labour pains On examination patient

was found to be moderately anemic Hb was 8.4 gms and platelet count was 1 lakh,10

thousand , Emergency LSCS was done for CPD with fetal distress. Two hours after

surgery , patient developed abdominal distension and difficulty in breathing,ultrasound

abdomen & pelvis was done it showed that there was some fluid collection in the

peritoneal cavity. Emergency Relaparotomy was done, uterus was found to be atonic

stepwise devascularisation was proceeded, the patient platelet count was 50,000 and

elevated liver enzymes was there , diagnosed as partial HELLP and DIVC. Patient was

connected to the ventilator,totally 9 units of packed cells, 26 units of fresh frozen

plasma, 16 units platelets, 4 units cryoprecipitate was given. In the post operative period

she developed wound gappimg,for which wound resuturing was done

106

11. SUMMARY

This prospective study titled as Incidence of preeclampsia in 200 antenatal anemic

mothers attending the tertiary care referral center and maternal mortality in anemia

associated preeclampsia was conducted at Govt.KasturbaGandhi Hospital for women

and children,Madras medical college, Chennai,during the period of December 2012 to

December 2013 .

Sample size was 200 antenatal women with anemia ( hemoglobin concentration less than

11gms)

The observation of this study were the following

• Most o the patients in the study population were in the age group20-29 years (72%).

• 48.5% of the patients were second gravida.

• 77.5% of the patients were belonging to class IV socioeconomic class.

• 99.5% of the cases were booked Of this 70% were booked at KGH.

• 27% of the cases were referred from other hospitals of these 14.5% had hypertensive

disorder,5.5% of the cases had severe anemia.

• 41.5% of the patients in the study population were in the weight group 60-70 kg .

• 76.5% of the study population were in the term gestation.

• 83% of the patients were moderately anemic.

• 11% of the patients were severely anemic.

• 85% of the study population were microcytic hypochromic peripheral smear picture

and 15% were normochromic normocytic picture.

• Incidence of severe preeclampsia was 11.5%.

• Incidence of mild preeclampsia was 7%.

107

• 11.5% of the patients had 1-3gms of protein in 24 hours urinary collection.

• 13.5% of the patients were treated with Magnesium sulphate regimen along with

antihypertensive drugs.

• 73% of the study population had spontaneous onset of labour,20.5% of the cases

labour was induced .

• 46% of the cases delivered labour naturally,31.5% of patient had primary caesarean

section,14.5% had repeat caesarean section, Instrumental delivery constitutes about

4%. Vaginal birth after caesarean constitutes about 0.5% .Spontaneous expulsion of

the fetus were occurring in 1.5%.

• Indication for primary LSCS ;Fetal distress consistuted about 15.5%, Cephalo

pelvic disproportion consistuted about 6.5%,Failed induction -3.5%, Severe

oligohydraminos-3%, Preeclampsia-2%, of the study population

• Maternal outcome; AtonicPPH -6%.Pulmonary edema -1.5%, Death occurred in

one case in the studypopulation.Both HELLP and DIVC occurred in one case

0.5%.Abruptio placenta occurred in 1%.Eclampsia occurred in 2% of the cases.

• 77.5% of the babies were term babies.Preterm babies constitutes about 7.5%. IUGR

babies constitutes about 12%.3% of the babies were dead 1.5% intrauterine .1.5%

perinatal death.

108

12.CONCLUSION

In most of the developing countries, anemia during pregnancy is the major problem

causing maternal morbidity and mortality and adverse neonatal outcome. Anemia is

responsible for both direct and indirect cause of maternal mortality. Anemia was the

direct cause for 20% of maternal deaths in India. The indirect causes of death due to

anemia was constituted about 20% It may be due to cardiac failure, post partum

hemorrhage, infection and preeclampsia .One of the most important complication of

preeclampsia is eclampsia , which was the direct cause of maternal mortality of about

13% in India. The incidence of preeclampsia was increased more so when it was

associated with chronic severe anemia and hypoproteinemia.

The coexistence of preeclampsia in anemic women’s worsening the situation. In

preeclampsia, there was already intravascular volume depletion hence anemia gets

masked the patients are not able to cope up even with mild blood loss during delivery, In

anemia associated with preeclampsia, even a small volume of blood loss of about 200ml

during the third stage of labour causes postpartum collapse and death if the blood loss

was not adequately replaced with blood transfusion. The fluid management in severe

preeclampsia with anemia is very difficult task in view of leaky pulmonary capillaries

that would result in volume overload, and pulmonary edema.

Various researches had shown that, during the antenatal visits less than 50% of pregnant

women were getting health education about preeclampsia and long term complications of

hypertensive disorders of pregnancy in the western population. In India most of the

pregnant women were unaware of the anemia and hypertensive disorders of pregnancy

and its complications. We have to counsel the pregnant mothers during their antenatal

109

checkup regarding the importance of blood pressure monitoring, screening and

correction of anemia prior to pregnancy and Iron and folic acid supplementation.

The risk factors of preeclampsia, any excessive weight gain ,any pedal edema which was

not relieved by rest and signs of imminent eclampsia should be informed to the antenatal

women, so that when it appears ,they would reach the nearby Emergency obstetric center

on right time, this requires community participation.

The data from National Nutritional Monitoring Bureau (NNMB) stated that the intake of

iron and folic acid in all the age groups were still low even after the implementation of

National Anemia prophylaxis programme.

In this study we had three near miss cases, all the cases were referred from primary

Health Center as preeclampsia with anemia, during their stay in the hospital, they

developed both the complications of anemia and preeclampsia like postpartum

eclampsia, pulmonary edema, HELLP syndrome and DIVC. Being a Tertiary care

Institute we were able to manage them successfully hence those cases were grouped

under Near Miss cases .The delivery of the preeclamptic anemic patients , should be

conducted in the Tertiary Care center with High dependency unit along with neonatal

intensive care unit, and blood bank .Careful monitoring of both the mother and baby

and anticipation of severe complications like eclampsia , postpartum hemorrhage,

abruption placenta, pulmonary edema, HELLP syndrome readiness to tackle those

complications will go a long way to reduce the maternal morbidity and mortality. The

Tenth plan strategies has to be effectively implemented to all pregnant women with

anemia to reduce the maternal mortality and morbidity and long term consequences of

anemia.

110

BIBILIOGRAPHY

1.AbdelAziem A Ali1, Duria A Rayis2, Tajeldin M Abdallah1 Severe anaemia is

associated with a higher risk for preeclampsia and poor perinatal outcomes in Kassala

hospital, eastern Sudan www.biomedcentral.com 1760500/4/311

2.Fernandez G,Diez EM The Cochrane Central Register of Controlled trials 2011 Issue

4 , , -Interrelationship between iron deficiency anemia and impaired renal function in

toxemia of pregnancy- EMBASE 1978106114

3.Th Masoomeh Goodarzi Khigani, Shadi Golie relationship of hemoglobin and

hematocrit in the first and second half of pregnancy with pregnancy outcome * IJNMR/

February 2012; Vol 17, Special Issue S

4.Emre Karashin,Seyit Temel Ceyhan-Maternal anemia and perinatal outcome . Perinatal

journal December 2007 Volume 15 Issue 3

5.Vitthal G.Kuchake, Sunny G.Kolhe-Maternal and Neonatal outcomes in preeclampsia

syndrome. International Journal of Pharmaceutical Sciences and research 2010 volume1

issue 11

6. Liu, Shiliang MD, PhD; Joseph, K. S. MD, PhD; Liston, Robert M. MD;

Bartholomew, Sharon MHSc; Walker, Mark MD, MSc; León, Juan Andrés

MD,Incidence, Risk Factors, and Associated Complications of Eclampsia

7.M. Dr.Pankaj Kumar, Dr.Prasad Pore, Dr.Usha pat maternal anemia and its impact

on perinatal outcome in a tertiary care Hospital of Pune, in Maharashtra Indian

Journal of Basic and Applied Medical Research March 2012 Volume 1 issue 2

111

8. MA Brown, CMakenzie, W Dunsmuir Can we predict recurrence of preeclampsia or

gestational hypertension, BJOG 2007 114;984-993.

9. James .N. Martin ,Brian K.Rinehart The spectrum of severe preeclampsia

Comparative analysis by HELLP syndrome classification,-American Journal of

Obstetrics Gynaecology1999, volume 180, Number 6, part 1.

10. .Ayaz A, Muhammad T, Hussain SA, Habib S Neonatal outcome in pre-eclamptic

patients.. Journal of Ayub Med Coll Abbottabad 2009 Apr-Jun volume;21 issue (2):

11. Mohammad A Salahat and Abdallah I. Ibrahim Jordan Prevalence of anemia among

Jordanian Pregnant Women and the effect of early pregnancy on Alakaline phospatase

activity Journal of Biological Sciences March 2012 volume 5 Number 1

12. Jamaiyah Haniff , Anita Das Anemia in Malaysia; cross sectional survey -. Asia

Pacific Journal of Clinical nutrition2007 volume 16 issue 3 .

13. Historical Review of anemia British Journal of Haematology,2003, 122 554–56

14. Mandy J. Bell A Historical Overview of Preeclampsia-Eclampsia J Obstet Gynecol

Neonatal Nursing 2010 September ; 39(5): 510–51.

15 L Raman, AB Pawashe, P Yasod .Hyperferritinemia in pregnancy induced

hypertension and eclampsia. Journal of postgraduate medicine1992 April-June | Volume

38 | Issue 2 PMID:0001432830

16.Clinical obstetrics and gynaecology Volume 42 Number 3 Lippincott Williams and

Wilkins.

17 J.J. Zhang*J. Grewal M. Roosen-RungeA.P. Betran Lazaga.Severe . anemia, sickle

cell disease, and thalassemia as riskfactors for preeclampsia in developing countries

112

Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health

Volume 2, issues 191-192, July 2012 PII: S2210-7789(12)00059-

18 Khandait D W Ambadikar NN .Zodpey PS etal . Risk factors for anemia in

pregnancy J Obstet Gynaec of India2001 Jan –Feb 51(1) 42-44

19. F.Gary Cunningham Hematological disorders and Pregnancy Hypertension,

Williams Obstetrics 23rd edition ,

20 Dr.J.B.Sharma Anemia complicating pregnancy .Text book of Obstetrics 1st edition.

21 AUAlexander JM, Bloom SL, McIntire DD, Leveno KJ .Severe preeclampsia and the

very low birth weight infant: is induction of labor harmful? Obstet Gynecol.

1999;93(4):485. PMID10214819

22 Iron parameters .Harper biochemistry 22nd edition.

23.D. C.Dutta Medical disorders in pregnancy Text book of Obstetrics seventh edition

24 Ram HariGhimire Sita Ghimire .Maternal and Fetal outcome following severe

anemia in pregnancy, and Journal of Nobel Medical college 2012 volume 2 No1 issue 3.

25. - Anthony R Gregg Hypertension in pregnancy -Obstetrics and Gynaecology clinics

of North America 2004 volume 31.

26.K.Kalaivani Prevalence of and consequences of anemia in pregnancy Indian J Med

Res 130, November 2009,pp627-633.

27.Jane Strong and Jane M .Rutherford, Anemia and white blood cell disorders High

Risk Pregnancy Management Options Fourth edition chapter 38.

113

PROFORMA

1. Name : __________________ IPNO : __________

2. Address: ________________ Phone : __________

3. Referral : Y / N DOA : / / 2013

4. Booked : B/ UB Immunized : Y / N

5. Age : (a) < 19 (b) 20 -29 (c) 30-35 (d) 36<

6. Obstetrics code :_________

(a) Primi (b) G2P1L1 (b1) Previous LSCS (b2) previous FTND (c) Abortions

(d) G3P2L2

7 Socio economic class : (a) I (b) II (c) III (d) IV (e) V

8Educational qualification : (a) IL (b) Primary (c) Middle school (d) High school

(e) HSS (d) degree

9Weight of the mother : (a) < 50 kg (b) 50 -60 kg (c) 60 -70 kg (d) 71 <

10Expected date of delivery : / / 2013

11Past obsterrics history :

(a) PIH (b) IUGR (c) IUD (d) Preterm (e) GDM (f) Perinatal death (g) Still

birth

12Past medical history : (a)Heart disease (b) hypo thyroid (c) Seizure disorder (d)

TB (e) Fibroid (f) Br.Asthma (g) DM (h) Previous Blood Transfusion (i)

Jaundice

13. Family history: (a) present (b) absent

14. Gestational age: ________

(a) Term (b) 36-38 weeks (c) 34-36 weeks (d) 28-35 weeks (e) < 28 weeks

15. Blood pressure:

(a) 120/80 (b) diastolic BP 90 (c) diastolic 100 (d) 160/110 <.

114

Investigation:

16. Heamoglobin:

(a) 10 -11gm (b) 7-10gm (c) < 7gm

17. Peripheral smear: (a) Microcytic hypo chromic (b) Normal study

(c) macrocytic hypochromic

18. Urine albumin: (a) nil (b) trace (c) 1+ (d) 2+ (e) 3+ (f) 4+

19. 24 hrs urinary protein: (a) < 300mg (b) 300mg -1gm (c) 1-3gm (d) >3gm

20. Anti HT drugs: (a) Yes (b) No

21. MgSO4 regimen (a) Yes (b) No

22. Other pregnancy complications: (a) Prev IUD (b) breech (c) Prev LSCS (d)

PIH

(e) GDM meal plan (f) GDM on insulin (g) heart disease (h) placentaprevia (i)

fibroid

(j) Twins ( k) VBAC ( m) Rh negative

23. Onset of labour: (a) Spontaneous (b) Induction – (b1) Postdated (b2)

Preeclampsia

.(b3) Imminenteclampsia (b4) others

24. Maternal Outcome: (a) Atonic PPH (b) wound infection (c) Pulmonaryedema

(d) death

(e) HELLP syndrome (f) DIVC (g) Abruptioplacacenta (h) ARF ( i)

Eclampsia( AP/IP/PP)

25. Mode of delivery: (a) Labour natural (b) Primary LSCS (c) Breech (d) Rpt

LSCS

(e) Instrumental (f) Rpt LSCS with ST (g) Rpt LSCS with CuT (h) VBAC

26. Fetal Outcome: (a) Term (b) Preterm (c) IUGR (d) Still born

115

27. Birth weight: (a) < 1.5 kg (b) 1.6- 2kg (c) 2 -3kg (d) 3 - 4 Kg

28. Treatment: (a) Oral Iron (b) IV/IM iron inject ion (c) Blood Transfusion

29. Renal function test: (a) Normal (b) elevated

30. Platelet count : (a) >1 lakh (b) 1 lakh to 50,000 (c) < 50,000

31 Liver function test: (a) Normal (b) Elevated

32.Last child birth;(a) 1-1year 6months (b)1yr 6 months-3years (3)>3years.

33.Indication for LSCS (a)fetal distress (b)failed induction (c)severe

oligohydraminos (d) severe preeclampsia(e)previous LSCS in labour (f) previous

LSCS at term (g)cpd minor (h)twins delivery.

116

117

118